ࡱ>  Ոbjbj 2Kr|  (   8WTd8/(((.......$13x. Z"$(Z"Z".  .&$$$Z"  .$Z".$$V,@-@V=Yp"-..<8/+-T44*$L44-44 -($td(((..v$d(((8/Z"Z"Z"Z"44((((((((( :  directionS the national health service act 2006 The Primary Medical Services (Directed Enhanced Services - Pandemic Influenza (H1N1) Vaccination Scheme) and Statement of Financial Entitlements (Amendment) (No. 6) Directions 2009 The Secretary of State for Health has consulted in accordance with section 87(4) of the National Health Service Act 2006() with the bodies appearing to him to be representative of persons to whose remuneration these directions relate. The Secretary of State for Health, in exercise of the powers conferred by sections 8, 87 and 272(7) and (8) of the National Health Service Act 2006 give the following directions Citation, commencement and application  LISTNUM "seq1" These Directions may be cited as the Primary Medical Services (Directed Enhanced Services - Pandemic Influenza (H1N1) Vaccination Scheme) and Statement of Financial Entitlements (Amendment) (No. 6) Directions 2009 and shall come into force on 30th October 2009. These Directions are given to Primary Care Trusts in England. Interpretation In these Directions the Act means the National Health Service Act 2006; APMS contractor means a person with whom a Primary Care Trust is entering into or has entered into arrangements for the provision of primary medical services under section 83(2)(b) of the Act; appropriate dosage means the recommended doses of the H1N1 vaccine as specified in the vaccination schedule in annex A to the letter signed by the Chief Medical Officer, the Chief Nursing Officer and the Chief Pharmaceutical Officer dated 15 October 2009 and published on the website of the Department of Health under Gateway Reference 12781(); contractor, unless the context otherwise requires, means an existing contractor or a new contractor; existing contractor means a person who on or before 30th October 2009 has entered into a GMS contract with a Primary Care Trust; or has entered into a PMS or APMS Contract with a Primary Care Trust; and has a registered patient list; GMS contractor means a person with whom a Primary Care Trust is entering or has entered into a general medical services contract; H1N1 vaccine means the Pandemic Influenza Vaccine (H1N1) 2009; new contractor means any person, other than an existing contractor, with whom a Primary Care Trust is contemplating entering into or has entered into contractual arrangements to provide vaccination services as part of its Pandemic Influenza (H1N1) Vaccination Scheme; PMS contractor means a person with whom a Primary Care Trust is entering into or has entered into section 92 arrangements for the provision of primary medical services; primary medical services contract means (a) a general medical services contract; (b) section 92 arrangements which require the provision of primary medical services; or (c) contractual arrangements for the provision of primary medical services under section 83(2)(b) of the Act; primary medical services contractor means (a) a GMS or PMS contractor; or (b) a person with whom a Primary Care Trust is making or has made contractual arrangements for the provisions of primary medical services under section 83(2)(b) of the Act; priority group is to be construed in accordance with direction 4; registered patient list is to be construed in accordance with regulation 2(2) of the (Primary Medical Services (Sale of Goodwill and Restrictions on Sub-contracting) Regulations 2004(); SFE means the directions given by the Secretary of State in the Statement of Financial Entitlements under section 28T of the National Health Service Act 1977(), signed on 30th March 2005(); and working day has the same meaning as in the National Health Service (General Medical Services Contracts) Regulations 2004(). PART  SEQ Part_ \* arabic 1 Establishment etc. of Pandemic Influenza (H1N1) Vaccination Schemes Establishment etc. of Pandemic Influenza (H1N1)Vaccination Schemes Each Primary Care Trust must exercise its functions under section 83 of the Act of providing primary medical services within its area, or securing their provision within its area, by (as part of its discharge of those functions) establishing, operating and, as appropriate, revising for its area a Pandemic Influenza (H1N1)Vaccination Scheme, the underlying purposes of which are to ensure that patients in its area who are in a priority group are offered the H1N1 vaccine; to ensure that the priority groups are prioritised for vaccination in the order set out in direction 4; and to maximize the level of uptake amongst priority groups in its area of the H1N1 vaccine. Priority groups The following groups are priority groups for the purposes of these Directions people who have reached the age of 6 months but have not reached the age of 65 years; and are in a clinical risk group listed in the Schedule to these Directions; women who are pregnant; and are at a stage in their pregnancy for which the H1N1 vaccine is licensed for use; people who are household contacts of immunocompromised individuals; and people who are aged 65 or over; and are in a clinical risk group listed in the Schedule to these Directions. Offers of arrangements to participate in the Pandemic Influenza (H1N1) Vaccination Scheme  LISTNUM "SEQ1" \l 2 As part of its Pandemic Influenza (H1N1) Vaccination Scheme, each Primary Care Trust must, subject to paragraph (2), offer to make arrangements with existing contractors or, where necessary in order fully to meet its obligations under direction 3, new contractors for the vaccination of patients in priority groups against pandemic influenza of the virus sub-type H1N1. Each Primary Care Trust must before offering to enter into arrangements with new contractors before 13th November 2009, offer each existing contractor in its area the opportunity to enter into arrangements to participate in the Pandemic Influenza (H1N1) Vaccination Scheme; and afford each of those existing contractors a reasonable opportunity to participate in the Pandemic Influenza (H1N1) Vaccination Scheme, but for these purposes, if an existing contractor fails to respond to an offer within 14 days of the date on which the offer is made by the Primary Care Trust, that existing contractor is to be treated as having been afforded a reasonable opportunity to participate in the Pandemic Influenza (H1N1) Vaccination Scheme and the offer may be withdrawn; before entering into arrangements with contractors, satisfy itself that the contractor is capable of meeting its obligations under those arrangements; and in particular, has the necessary facilities, equipment and suitably trained and qualified general practitioners, health care professionals and other staff to meet those obligations, and nothing in these Directions shall be taken as requiring a Primary Care Trust to enter into arrangements with a contractor if it is not so satisfied. A Primary Care Trust may withdraw an offer to enter into arrangements with a contractor as part of its Pandemic Influenza (H1N1) Vaccination Scheme if the contractor fails to provide any information requested by the Primary Care Trust which that Primary Care Trust reasonably requires in order to satisfy itself as mentioned in paragraph (2)(b); and within a timescale reasonably requested by the Primary Care Trust. Form and content of the arrangements  LISTNUM "SEQ1" \l 2 The arrangements that each Primary Care Trust, as part of its Pandemic Influenza (H1N1) Vaccination Scheme, enters into with contractors who are primary medical services contractors with a registered patient list must be contractual arrangements, in writing, which include the following a list (the housebound patients list) of those of the contractors registered patients who are in a priority group but who are housebound (that is, they are a patient to whom the contractor would normally offer home visits as the only practical means of enabling the patient to consult a general practitioner, face to face), and a provision to the effect that (i) the contractor is not under an obligation to offer a patient on the housebound patients list the H1N1 vaccine; and (ii) the Primary Care Trust shall not recover the cost of administering the H1N1 vaccine to those patients on the housebound patients list from the contractor; the arrangements under which the Primary Care Trust will supply H1N1 vaccine to the contractor; a requirement to provide the Primary Care Trust with such information relating to the contractors arrangements for administering the H1N1 vaccine that the Primary Care Trust requires for the purposes of co-ordinating the supply of the H1N1 vaccine and associated consumables to contractors; requirements that the contractor undertakes to adopt a proactive approach to offering the H1N1 vaccine, with a view to maximising uptake of the vaccine, which includes adopting robust call and reminder systems to contact patients in priority groups; and a programme of opportunistic vaccination of the patients in priority groups; offer the H1N1 vaccine only to patients in a priority group; vaccinate patients, in so far as is practicable, in the following order of priority patients in the priority group specified in direction 4(a); patients in the priority group specified in direction 4(b); patients in the priority group specified in direction 4(c); and patients in the priority group specified in direction 4(d); a requirement that the contractor takes all reasonable steps to ensure that the lifelong medical records held by the contractor are kept up-to-date with regard to the patients immunisation status, and in particular include any refusal of an offer of vaccination; where an offer of vaccination was accepted details of the consent to the vaccination where a person has consented on a childs behalf, that persons relationship to the child must also be recorded; the batch number, expiry date and title of the vaccine; the date of administration of the vaccine; where two vaccines are administered in close succession, the route of administration and any injection site of each vaccine; any contraindications to the vaccination; and any adverse reactions to the vaccination; a requirement that the contractor ensures that any health care professional who is involved in administering a vaccine has the necessary experience, skills and training with regard to the administration of the vaccine; and training with regard to the recognition and initial treatment of anaphylaxis; a requirement that the contractor ensures that all vaccines are stored in accordance with the manufacturers instructions; and all refrigerators in which vaccines are stored have a maximum/minimum thermometer and that readings are taken from that thermometer on all working days; a requirement that the contractor supplies the Primary Care Trust with such information as it may reasonably request for the purposes of monitoring the uptake of the Pandemic Flu Vaccine (H1N1) 2009. The arrangements that each Primary Care Trust, as part of its Pandemic Influenza (H1N1) Vaccination Scheme, enters into with contractors who are not primary medical services contractors with a registered patient list must be contractual arrangements, in writing, and in determining the terms upon which any such arrangements are to be made, the Primary Care Trust must have regard to the matters set out in paragraph (1) in so far as they are relevant to such arrangements. The arrangements that each Primary Care Trust makes as part of its Pandemic Influenza (H1N1) Vaccination Scheme must include arrangements for ensuring that it is notified when patients on any housebound patients lists are vaccinated in order to enable it to make appropriate payments, in accordance with direction 7, to the contractor on whose registered patient list those patients are registered, and those arrangements must include a requirement that where the contractor is vaccinating a patient who is not on a registered patient list held by that contractor, the contractor must ask the patient for the name and address of the primary medical services contractor on whose registered list of patients they appear, if any; and a requirement that if the patient provides any information requested in accordance with sub-paragraph (a), the contractor must provide the Primary Care Trust with such information which it reasonably requests in support of any claim by the contractor in respect of that patient, and may include any other provisions the Primary Care Trust considers necessary in order to enable it to make appropriate payments, in accordance with direction 7, to the contractor on whose registered patient list those patients are registered. Each Primary Care Trust must ensure that arrangements it enters into as part of its Pandemic Influenza (H1N1) Vaccination Scheme with any contractor who is a primary medical services contractor (irrespective of whether such contractor has a registered patient list) take effect as variations to that contractors primary medical services contract. The termination provisions in relation to the contractual arrangements in relation to the Pandemic Influenza (H1N1)Vaccination Scheme must in all cases provide that either party may withdraw from the arrangements entered into as part of the Primary Care Trusts Pandemic Influenza (H1N1) Vaccination Scheme by giving 21 days notice in writing; and if the contractual arrangements relating to the Primary Care Trusts Pandemic Influenza (H1N1) Vaccination Scheme comprise only part of the arrangements that the contractor has made with the Primary Care Trust to provide primary medical services, the provisions providing for termination of the Pandemic Influenza (H1N1) Vaccination Scheme arrangements by giving 21 days notice must be in addition to any other termination provisions under those other arrangements. The amount of payments relating to the Pandemic Influenza (H1N1) Vaccination Scheme in the case of primary medical services contractors who vaccinate patients on their registered patient list  LISTNUM "SEQ1" \l 2 The arrangements that each Primary Care Trust, as part of its Pandemic Influenza (H1N1) Vaccination Scheme, enters into with primary medical services contractors with a registered patient list must provide for the payments specified in paragraph (2) to be made. In respect of each completed vaccination for a member of any priority group on the contractors registered patient list, the amount is 5.25 (where the appropriate dosage is two doses of the H1N1 vaccine, that is 5.25 per vaccination, but 5.25 is payable for the first completed vaccination in the case where the patient does not receive the second dose). The amount specified in paragraph (2) is payable to the contractor under the arrangements even if the patient vaccinated is on the housebound patients list prepared pursuant to direction 6(1)(a) and as a consequence the completed vaccination is not administered by the contractor, provided the vaccination is nevertheless administered under arrangements entered into as part of the Primary Care Trusts Pandemic Influenza (H1N1) Vaccination Scheme; or the patient vaccinated was vaccinated before the contractual arrangements were entered into, provided that the contractor was responsible for administering the vaccine, and the patient to whom the vaccine was administered was a patient to whom the contractor would have been obliged to offer the vaccine under the arrangements subsequently entered into, had that vaccine not already been administered. Procedure for claiming the payments relating to the Pandemic Influenza (H1N1) Vaccination Scheme in the case of primary medical services contractors who vaccinate patients on their registered patient list The arrangements that each Primary Care Trust, as part of its Pandemic Influenza (H1N1) Vaccination Scheme, enters into with primary medical services contractors who have a registered patient list must include arrangements for the submission of claims that relate to the vaccination of patients on that contractors registered patient list, at a frequency to be agreed between the parties, but which must provide for claims to be submitted within 8 weeks of administration of the H1N1 vaccine; or if no agreement can be reached, which provide for claims to be submitted before the end of the 14th day of the month after the month during which the H1N1 vaccine was administered; include the date on which the payment is to fall due (consistent with other due dates for payments under the primary medical services contract); provide for payments to be made subject to the following conditions that no more than two payments in respect of a completed vaccination are payable in respect of any patient; and that the contractor must supply to the Primary Care Trust with the following information in respect of each patient in respect of whom a payment is claimed the patients name; the patients date of birth; the patients NHS number, where known; confirmation that the patient is in a priority group; the date on which the vaccine was administered, but where a patient, parent or carer objects to details of a patients name or date of birth being supplied to the Primary Care Trust, the contractor need not supply that information provided it supplies the patients NHS number; include such other arrangements as the Primary Care Trust considers necessary for ensuring that the receipt and payment of any claims for payment made in accordance with direction 7 are recorded in a manner that ensures that each claim has a clear audit trail; and require that all information provided by the contractor pursuant to these conditions must be accurate. Amount of payments and procedure for claiming payment relating to the Pandemic Influenza (H1N1) Vaccination Scheme in the case of vaccinations other than vaccinations by contractors of patients who are on their registered patient lists  LISTNUM "SEQ1" \l 2 The arrangements that each Primary Care Trust, as part of its Pandemic Influenza (H1N1) Vaccination Scheme, enters into with contractors who are not primary medical services contractors with a registered patient list; or contractors who are primary medical services contractors with a registered patient list in respect of the vaccination of patients who are not on their registered list must include provision in respect of the matters set out in paragraph (2). The matters that must be included in the arrangements referred to in paragraph (1) are provision in respect of the amount agreed as payment under the arrangements; and provisions in respect of the manner of claiming payment under the arrangements, and in this respect the Primary Care Trust must have regard to the matters set out in direction 6(3) and 8 in so far as they are relevant to the arrangements. PART  SEQ Part_ \* arabic 2 Amendment of the Statement of Financial Entitlements Amendment of the Statement of Financial Entitlements The SFE is amended as follows. Amendments to Section 4 Section 4 (quality and outcome framework: general) is amended as follows for paragraph 4.15 (calculation of points in the patient experience domain), substitute the following  SYMBOL 147 \* MERGEFORMAT 4.15 This domain, in Section 4 of the QOF, contains three indicators, all of which relate to patient experience: the first is about the length of patient consultations and the second and third indicators are about patient experience of access. The method of calculating the number of points earned under the indictor relating to the length of patient consultations is set out in paragraph 4.16. The method of calculating the number of points earned under the indicators relating to patient experience of access is set out in paragraphs 4.17 to 4.18E. There are specific provisions in paragraph 4.18BA to 4.18BC in relation to the calculation of such points in respect of the financial year 2009/2010 for those contractors who enter into arrangements with the PCT to participate in the PCTs Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with the Pandemic Influenza (H1N1) Vaccination Directions 2009. SYMBOL 148 \* MERGEFORMAT ; after paragraph 4.18B, insert the following  SYMBOL 147 \* MERGEFORMAT 4.18BA If the contractor has on or before 31st March 2010 entered into arrangements with the PCT to participate in the PCTs Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with the Pandemic Influenza (H1N1) Vaccination Directions 2009 the PCT must, as soon as practicable after 31st March 2010, calculate the percentage of those of the contractors registered patients who are in the priority group specified in Direction 4(a) of Pandemic Influenza (H1N1) Vaccination Directions 2009 who have been vaccinated or are deemed to have been vaccinated under those arrangements by the contractor. For these purposes a patient is vaccinated under those arrangements by the contractor if they have received the appropriate dose as recommended in the vaccination schedule in annex A to the letter signed by the Chief Medical Officer, the Chief Nursing Officer and the Chief Pharmaceutical Officer dated 15th October 2009 and published on the website of the Department of Health under Gateway Reference 12781 (the appropriate dosage); and a patient is deemed to have been vaccinated under those arrangements by the contractor if they are on the contractors housebound patient list (as defined in the Pandemic Influenza (H1N1) Vaccination Directions 2009) and have received the appropriate dosage even if those vaccinations were not administered by the contractor; or they were vaccinated before the arrangements were entered into, provided the contractor was responsible for administering the vaccine, and the patient to whom the vaccine was administered was a patient to whom the contractor would have been obliged to offer the vaccine under the arrangements subsequently entered into, had that vaccine not already been administered. 4.18BB If the percentage calculated in accordance with section 4.18BA is greater than 50.7% the contractors points in respect of indicators PE7 for the financial year 2009/2010 will be calculated in accordance with the provisions of this Section but as though the minimum percentage threshold set out in Annex D in respect of that indicator was 50% and as though the maximum percentage threshold set out in Annex D in respect of that indicator were 80%; and the contractors points in respect of indicators PE8 for the financial year 2009/2010 will be calculated in accordance with the provisions of this Section but as though the minimum percentage threshold set out in Annex D in respect of that indicator was 40% and as though the maximum percentage threshold set out in Annex D in respect of that indicator were 80%. 4.18BC If the percentage so calculated is 50.7% or less, or if the contractor has not on or before 31st March 2010 entered into arrangements with the PCT to participate in the PCTs Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with the Pandemic Influenza (H1N1) Vaccination Directions 2009, the contractors points in respect of indicators PE7 and PE8 for the financial year 2009/2010 will be calculated in accordance with the provisions of this Section and on the basis of the financial thresholds set out in Annex D. SYMBOL 148 \* MERGEFORMAT ; and for paragraph 4.18C, substitute the following  SYMBOL 147 \* MERGEFORMAT 4.18C If a contractor has achieved a percentage result in relation to either indicator that is the minimum set for that indicator or is below that minimum (subject to any adjustment required in respect of the financial year 2009/2010 in accordance with paragraphs 4.18BA and 4.18BB), it achieves no points in relation to that indicator. If a contractor has achieved a percentage result in relation to either indicator that is between the minimum and the maximum set for that indicator (subject to any adjustment required in respect of the financial year 2009/2010 accordance with paragraphs 4.18BA and 4.18BB), it achieves a proportion of the points available in relation to that indicator. The proportion is calculated as follows. SYMBOL 148 \* MERGEFORMAT . Amendment to section 8 Section 8 (Childhood Immunisations Scheme) is amended as follows in paragraph 8.10, after the words unless the information the PCT needs to calculate the payment is supplied late and immediately before the table, insert the following  SYMBOL 147 \* MERGEFORMAT Specific provision applies in respect of the calculation of TYOIP in relation to quarter 3 of the financial year 2009/2010 i.e. the quarter commencing on 1st October 2009. If the contractor has on or before 31st December 2009 entered into arrangements with the PCT to participate in the PCTs Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with the Pandemic Influenza (H1N1) Vaccination Directions 2009, the final date for immunisations which count towards the payment for that quarter will be 11th February 2010 and not 31st December 2009 as would normally be required in accordance with the table below. SYMBOL 148 \* MERGEFORMAT ; and after paragraphs 8.20, insert the following  SYMBOL 147 \* MERGEFORMAT 8.20A Specific provision applies in respect of the calculation of FYOIP in relation to quarter 3 of the financial year 2009/2010 i.e. the quarter commencing on 1st October 2009. If the contractor has on or before 31st December 2009 entered into arrangements with the PCT to participate in the PCTs Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with the Pandemic Influenza (H1N1) Vaccination Directions 2009, the final date for immunisations which count towards the payment for that quarter will be 11th February 2010 and not 31st December 2009 as would normally be required in accordance with the table in paragraph 8.10. SYMBOL 148 \* MERGEFORMAT . Amendment of Annex A In Part 2 of Annex A (Glossary Definitions), after the definition of Non-GP provider, insert the following definition  SYMBOL 147 \* MERGEFORMAT Pandemic Influenza (H1N1) Vaccination Directions 2009 means the Primary Medical Services (Directed Enhanced Services Pandemic Influenza (H1N1) Vaccination Scheme) and Statement of Financial Entitlements (Amendment) (No 6) Directions 2009; SYMBOL 148 \* MERGEFORMAT . PART  SEQ Part_ \* arabic 3 Payments to PMS contractors and APMS contractors in respect of Quality and Outcomes Framework Arrangements and the Childhood Immunisation Scheme Adjustment of payment under PMS and APMS contracts in respect of the Quality and Outcomes Framework Where, under a primary medical services contract between a PMS contractor or an APMS contractor and the Primary Care Trust, the PMS contractor or APMS contractor participates in the Quality and Outcomes Framework during the financial year 2009/2010 and the payment arrangements agreed in respect of such participation are identical to those set out in the SFE in respect of the Quality and Outcomes Framework, and on or before 31st March 2010 enters into arrangements with the Primary Care Trust to participate in the Primary Care Trusts Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with these Directions, the Primary Care Trust must apply the payment provisions under such contracts, in respect of such participation in the Quality and Outcomes Framework during the financial year 2009/2010, as though amended in accordance with the provisions set out in direction 11. Adjustment of payment under PMS and APMS contracts in respect of the Childhood Immunisation Scheme Where, under a primary medical services contract between a PMS contractor or an APMS contractor and the Primary Care Trust, the PMS contractor or APMS contractor participates in the Childhood Immunisation Scheme during the financial year 2009/2010 and the payment arrangements agreed in respect of such participation are identical to those set out in the SFE in respect of the Childhood Immunisation Scheme, and on or before 31st December 2009 enters into arrangements with the Primary Care Trust to participate in the Primary Care Trusts Pandemic Influenza (H1N1) Vaccination Scheme established in accordance with these Directions, the Primary Care Trust must apply the payment provisions under such contracts, in respect of such participation in the Childhood Immunisation Scheme during the financial year 2009/2010, as though amended in accordance with the provisions set out in direction 12. Signed by authority of the Secretary of State for Health  Richard Armstrong A member of the Senior Civil Service Department of Health 29th October 2009 SCHEDULE Direction 4 Clinical risk groups People with chronic respiratory disease. People with asthma that requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations requiring hospital admission. People with chronic heart disease; People with chronic renal disease; People with chronic liver disease; People with chronic neurological disease; People with diabetes; People who are immunosuppressed. () 2006 c.41. () A copy of the letter may be downloaded from the website at http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_107169 () S.I. 2004/906. () 1977 c.49; section 28T was inserted by section 175(1) of the Health and Social Care (Community Health and Standards) Act 2003 (c.43). Section 28T of the National Health Service Act 1977 was repealed by the National Health Service (Consequential Provisions) Act 2006 (c.43), section 6 and Schedule 4, with effect from 1st March 2007. For corresponding provisions, which came into force on the same date, see section 87 of the National Health Service Act 2006 (c.41). () These Directions were amended by the Statement of Financial Entitlements (Amendment) Directions 2005 which were signed on 8th June 2005 but which had effect as from 1st April 2005, by the Statement of Financial Entitlements (Amendment) (No.2) Directions 2005 which were signed on 12th July 2005, by the Statement of Financial Entitlements (Amendment) Directions 2006 which were signed on 31st January 2006, by the Statement of Financial Entitlements (Amendment) (No.2) Directions 2006 which were signed on 30th March 2006, by the Statement of Financial Entitlements (Amendment) (No 3) Directions 2006 which were signed on 29th June 2006, by the Statement of Financial Entitlements (Amendment) (No 4) Directions 2006 which were signed on 2nd August 2006 but which had effect as from 30 July 2006, by the Statement of Financial Entitlements (Amendment) (No 5) Directions 2006 which were signed on 25th of September 2006, by the Statement of Financial Entitlements (Amendment) (No 6) Directions 2006 which were signed on 2nd November 2006 but which had effect as from 4th September 2006, by the Statement of Financial Entitlements (Amendment) Directions 2007 which were signed on 19th March 2007, by the Statement of Financial Entitlements (Amendment) (No 2) Directions 2007 which were signed on 2nd August 2007, by the Statement of Financial Entitlements (Amendment) Directions 2008 which were signed on 25th March 2008 but which came into force on 1st April 2008, by the Statement of Financial Entitlements (Amendment) (No 2) Directions 2008 which were signed on 21st April 2008 but which came into force on 1st April 2008, by the Statement of Financial Entitlements (Amendment) (No3) Directions 2008 which were signed on 7th August 2008 but which came into force on 1st October 2008, by the Statement of Financial Entitlements (Amendment) (No 4) Directions 2008 which were signed on 1st September 2008, by the Statement of Financial Entitlements (Amendment) (No 5) Directions 2008 which were signed on 22nd October 2008 but which had effect in part from 1st April 2008 and in part from 23rd October 2008, by the Statement of Financial Entitlements (Amendment) Directions 2009 which were signed on 29th January 2009, by the Statement of Financial Entitlements (Amendment) (No 2) Directions 2009 which were signed on 23rd March 2009, by the Statement of Financial Entitlements (Amendment) (No 3) Directions 2009 which were signed on 24th March 2009, by the Statement of Financial Entitlements (Amendment (No 4) and Specification of National Minimum Percentage Uplift) Directions 2009 which were signed on which were signed on 10th June 2009 but which had effect in part from 1st April 2009 and in part from 11th June 2009 and by the Statement of Financial Entitlements (Amendment) (no 5) Directions 2009 which were signed on 22nd September 2009. () S.I. 2004/291 as amended by S.I. 2004/906 and 2694, S.I. 2005/28, 893, 3315 and 3491, S.I. 2006/1501 and S.I. 2007/3491, S.I. 2008/528, 1514 and 1700, S.I. 2009/309, 2205 and 2230.     12` a  ' + f I K  # z{|} ٹٙ{jho0JUhoh;hTFh<hC hH66hy-h=3b'&چ(1)t lkY0p 0+?jhy-h=3Ub'&چ(1)t lkY0p 0+ hy-h=3jh=30JU hWh=3hCL h")h=3h=3/ 2   * ` # 1o[gd=3gd=3gd=3gd=3gd=3gd=3gd=3%gd=3gd=3gd=3 "#opijgh  *+,-Y+Jt"&23NOﲩhlUy hWh=3 hy-h=3 h3h=3hIkmHnHujh=3Ujh=30JU h{nh=3 h{h=3 h+h=3 hT$h=3ho h3uh=3hCLh=3hC hC hC aJ8Vpjl/3Xgd=3gd=3gd=3gd=3FEƀ&gd=3gd=3gd=35 Zf m#} 'h!!^!!X"$gd=3gd=3gd=3gd=3gd=3gd=3gdlUylm~npqs}!!!!!!##$$$$)%;%<'\'''''''>(r(()g)k)o)))))ԻԻ hT$hX1hhXh4hX1h1xheqhQ#h^hC hC aJhH6hC hWh=30h=3b'&چ(1)t lkY0p 0+9jh=3Ub'&چ(1)t lkY0p 0+ h@2h=3hCLh=32X""#P$$$%\''t(())***F+++,P,,,--.gd=3gd=3  & FL^Lgdeqgd=3gd=3gd=3gd=3$gd=3)**?+A+++,,N,O,,,,|-}---...../|/}////R0V000~11%2K2L2^222222222=3O377'8.8/8384888O8l8888888;;;z;;(<:<^<_<<<==w>>> hKh=3 hWh=3 h!h=3has h:h=3h@ehCLhh=3P.../~///R001411224s6789;;d<6>>@{Agd=3gd=3gd=3gd=3gd=3gd=3gd=3>> ??g?y?@@:ALAsAxA)C;CE FGGII@JAJ]J^JJJJJKLLLL L0N1NFNGNNN!O"O#O%OOOoPpPPPQQQQQQžźŶŲžžŲŲŲŲŲŲŮŮŮžŮŪŲţŮŜŔŔjh=3U hy)h=3 hlVh=3h;hfh@eh`a0h1 hWh=3h=30h=3b'&چ(1)t lkY0p 0+9jh=3Ub'&چ(1)t lkY0p 0+7{AA@CCCDEmFGGJHH!II.JBJ_JJJJgd=3gd=3gd=3gd=3gd=3gd=3JKLCM/NN&OOPpPPQQQR-3(v q2BCXat"CV@)g~Ty.${!GGU+O*0(Yĸ0 5ӏZkAeD9z? bc?b]?s`#:u YC7 Ł0 Ɖ>!*"=b~MaxI Ɠ(t4]U&6esEIm9E#ڵq*ClmuV-SoѠ~im̓MgK`}OHTJU ]uMewpxm},tkIXw +K}Sb'j{V~b&ƚ:)+ȍ`d1?$v7Ozpx؊ +3mmT*65LVP_-2ȯUQJSr&s" TBr;L͠S 4vѭ~[xdń@b{Qm ͎paQ H:'ם#Dd%TU GY~aZl w]e]UU vFM\rxLiRN5QU5?82d)L#6[S@ȶ~S`Pj"I0;*c1qz4oj9A@4tYx L@'̨\'⦈ٯ `Š=XɨJ7;?|ߞ?HvF7UDTO8\#ԙ@ ÏophC&@/9M-uW2_F\r_':7KlFeJY/q:K_7@%ĝU8xYl>y~A}^(q޶FZ@Ĭ~K\tE**aWB׳H5)af˭qprzDi2'T%DC5""3eïN\@u k9MƒHFt*O/8>bU"y>:lpn7cȜ:)$(f۩d VP2 DB|Wm-o7- Hu-*H7oI5[73o|ǀ WBJ8eU< 5r 8i- <:ڪjzìRV0gث~ rxA5ruwPŸg*H\~M".Q$I%K+h+Y7܈7i XeZ3ҧTmY9kgU C;xk}d5Cf}N3i)axgީ˽4 dX} I9l|m<)sS>,8-[?w[}b3yBu۔CJk-^/՟"JܮgY͘cWX"; z3;X9m7 !)f15LČf|s*b?_>XITvUq\:L*:bxe` 4ްS>jT -Z98iׅuD:ڪ|vA6RGz=oe(&_k'w[xA2WN#w$tC@{$_UѨD3OjnQj1NbOY90j_umM]~~x](UuPU:C =.gkuN1f%i!lp,E]X4He iZ3xL P@gn2'bBHlij\h |lڐ> ب#K8T?3Z{iiػnh _q2it(|A$[ad+E)hEzb>\'!R}FGU֚ڹf>(XQ$8Tn{fkϵ@ 86wv8Vu 6F@vbsCTvRu gQ 3̚\%*+"Щ:6 X;$ؾ 2e9!,V:ٗ'(H+foOȈ{5G'T@cZ"F^h T%Bz˔=Wx渙"^~zDPw \z;[@`n :cTVjGHhޓN ]>Mi7Oe$xS QZׯ)zՃbXm-wJ[ܼk2A{ǧj@ꛦF80IA:k0%kе]_Qƕ&O¹Snyn8oMX33lx)u6h:,h"͢ܪNB{(׶D$12d _zΈLҪQhb΢7\̜`bS7?A߀k!8/pߧ27wAɴ2_F`Jj'DʹWViOmJ.,3͓K1Y9TG~ U NCL U(:jܴF}SHm*ەa+y+ #D6^O(^Kz>g[){,&N[!cH6_H(prUTW5?$@؞RVEI&1JO8uG4IwliĐ)T/s=ڒiL>Nktcj/;DvrP줌d=E]d!z]Ô;OS!˵@`ΟS-ґ½wn|jP5װ¸ީ@J!@ӭh gkwoT`TfM2HL/06uYctyUN*ɬ%r#$ɪe?'@Z^)<5B6nP풣U&[va:w#70pvQ(JH) 2%?91 T(e:uʽ#$ͬﺵ3nfW/":A_ Oڒg4@PԦ<67U bkn!9`m*q~5_+a<Z䴴vDe/Sh =l}}/gsYt'+*"҆I=,$bjR۹l=&l;canweV'4l]۵I+З#l\Y)r((<)u#DF͸e ?(]d3eQ$P=R?,ƈҕzRC\,m?'|6hp$<ۭV;x67 e**5h:N`oʝ hCeig_: QK=-Nj@{oӆ =?wt,|Z~Oƫ.9mCS{O֣0Ci{Noѱrmq }3,) 8jv}: @ZUڏì<%ò}Շ-^<ԢF/M񂀔-#6~'YE+1PBn%N H>lJqqL4 6MEx ͔|_Uc0 LJiYCIj-e3c<Ti[ P3q!r5|rB|oUN|onX,t]&~oWVYk@kGxԯMM0 ʺ ײP|mU|_J0J ,g_Pi- 6^80(>Dže*Ψ p6rY&e`'"f,v+kveے&#-lֺ@o;7W_/).v| I7W؇A;3@:nRN V,Eg$Z "S4\z-pym*,&rGiK!{YSRlwA3+ߪ [UILաሣBlyf 6‰bG )&SGc{k+`ۀe@ `Sa04H} )%E)UU/yoiGq)H6kΟ5c/rПQ '52`iPNhfhe) sUKtw2obN-0^UWF v3K4N:Qg^ci)獷f1MY (R{aghy|B̨Ko<*V[ĵ=> 8q?Oz{fZP̌Գ6#uoOxo N $/X!B[7I䕊1PYf:`F5oΓ֒-FH1" g8#Mr<*Z!œxYƃ0Tw0iuU4tc4*PY[&]./,Ea4?iPY}wg*e`05$M7Nj4:u׏)dn wLRooqK;LPL5GMelyߡ;<}uUWY4y#0[Icmj'm\ pzYC B)1u>*27RG2?Bref"knόUZݢhW{ZrmbdFTȄ3{9h}&b[F#;)%qԲ1ByKWVn)?XzdԻ\K7 9bʐu«kNhzC?iN^p_$t (.IH 1a)7`P˕U8F#Aச~V )c:CUƞN;d'b%UW:'RSʪp;7/Rv؞#ۏ,hEV[ϭ,*Py85i &A.QtKsbÙL򬕒椏 '/?zKm omqu\Lva^ j-[]}5w яUylN1J Nu侑&@J7S0=%.Q+c#x>*p'bIM >WhS5b2{oZPt3gBX:U6zzkqnc.emzQۿ08ó#]'8B"L"G `WtM'TvFaoxPobiݓEۤjY_).8(@|=)"9jubB/Xt:֥=YG ެ+vxyv-SiA׶mq$ AAtp~/G++s=)춱+wC*S7}R7xHNT YNI1tGtνz M[G7  I$+OMaOY6FKuCRn;Zt8 8`jP̖+Cvh,;;?`;5m|Vկ?⺜eGdžkX _yVek[-&t*^"J^S`̋e)VlPq!:5.52^z咭vH: sjjbZJcAgPL$9xtI0Z&s4v}>S-ʜݖHajQ7ۂtsZ1K%xU3֎aF{myyjw灳ޜ6 3eVczwQdJ]*0p&kP'ZП`-7u=Fsvԭh/y Q:Spld}>Q 1!lSzPq}rfn]Wi@~N؀4|PaEAF1N_5 +PB{)7/իu1dKg6q.ȃ?Va.ܚVl&)ơ/֣oZAztG򍪮LSD20 "Zrٱ &8lxZLeF@`@W8v Q }}a$I Ӣ!ճW_@ XppUsu&S;߉FLO9ɱK IV' 9 amz`.8%ZQKrCʻ{&TrWJ09M}D HţgJ?W3`S{gl.\j,.ox}!+au;VX۹r?cȉ#n#n<&Q؅vs;>lzh_ږUaMqAh Aގ?l8Y X/脢uu!ycΰs6g + <ںsZ_c*qUطF%K)Q@­o@Jon{d G KՎTGW;fQR0kM]ђ;Q1%nSR LjR*ǔi&w4; 27!zrb+O{%xl%]Ah&pTڦmqnef=rnl¾k4,B mꋱ^qIs ܆4_;uj58z7T&r[C%խ/Au< 7WCaCRc,,)Yv6 >pao2g&xXI IxBjkO.,]*|T>[Eӭ@ WOFpJt2Bom@X\CKrҰݐ&ޓvH>`# +͏qԠ(xؾo=Uh]kewgKѡQN=O&Yk,/R!_pE" wzD %>H)wXVkd5%PP"7$YҠIjBM)*6 2y Dž*CB-Z65涚JS4 bk^} F ɴvZXsxԊJ\5UbѫS87YwVbXt %alnjX5inڑQOUy+s@ IzbL~£ӗsqn6i80clydb,l2GHYeײ()"[-z;Yڞ_X[S/We_6۪k>+٣L סݟ|_y¹iێZ.#Fi {QE{\.`ة/Ѫ{jK _|>wEzNW 7wa+elQe*"HN&yfזۯ~XC,?VS)cxϷӾ6C@]x9Eb]!%IGc'i[4<&43CN`FNae(B#%2 GZN 7`kR9"+b(y` q] v)ڑfgu>*Ā *# x>L>ƺ^!ȩ9 F(?r)ѡ.Pw3p帹 I%%b.)ۓ`@>FbI >irF0r 2+* QkO> o[lq-S nRߴCɊK-tTcp< 7KS7uz%:h:3L載8߹r=+@wi-SL[ȩâUx#6K ݲ#8!+D|d4օE#Xzt, 1)ƙ / -M vxf~ܿ+cSvsZ+ưy{ y± !0S0t{x|6,Ёlg;a:~bAg-Aݻ")S: GK" UQJ(^[" t5YZwYiAkPp6%i'!pepʩyb{=-f0T)R£,PDvOڧ 8d/un ?\F:ي8F7<718ipb Tax>eX; v]ѩxf1ca7St8ڏR@w.'<vVISf}eq$Ge+Ɯхrtt%Ycg_N,N@WRD̼J#|D/BT5zx X.LkA3k7+yR3y f nŞiWWC BlHkz|GCP[{>}|]_Y wS'Nv٣v 얝}~&-D id!3F}RhkBu6I{~5,f6Ox.ڷg95\@qvZ.ߴtyqcA^Ńm΁\-#Y3PUCk"o@N s| CY=罍edmuJz&wЛ~Dp~ZL؅ST n\}ƒ9wbu1zxr*pm5"/[pǢ^iUt+&%S̅r88rl"XۻȦ$(P $~Zh:M}F]7ǟX |^M65J9?6@aސP,u647>]K8g-?踋fR|IRМ㿦R$ز$G\.߾ _`dyp^C{.A|v23Nݼ]UE@wM@jn*[n,D\ߓgrJK8F7̎Jh]Ə]'*jen =i<iF*'6թ3Qe>0Q$;ˁ(vl(8<h6v݆TV>%ZTE=T sFtsFpoN-m(37n:>޺cra7Z=^EdBd,Vxu4jث=А[۹ں1r_–/~TTY*T% Eɂ(&]L5'V~oPCǬhVwnUϥ}*U @Arq߼<`=5s~fBkW $߭5~k]Pr#%}?qcԇ1DQ:6'^D;`qSTQ?rvӧ$;d@RtOzF'DhA\v:'W@M簝+F 2JDDCw i+upYH1՟6Y%䫐yyLo?]@34KMT%^&S}gdN%t 譾1R$vu0Xk@~?V.7hm㱊7@Fu(,ȼLvo ?bDORx@:@Up1HiDeL)iZ v tf- \$fƐ )~ڽ싩Exq-~xIӕvThbH84pT㯿H>C.* ܞ%Ï"& zs1j $)^n* 4ZbpՕƸg`5 Ԃv[w.GRɋugy;fs^FӲ[x~*H.F> kz vO{kDU7vD(ϣCb:_2[d^s = "YU-]1LOmbN뛼<04 VL RveVnXJ%JnK]v&N @hO#5װ1ߎ0r[pdqZ!e;2EÜB]qs` ʉ1ӎuMϥef?LRvBM` Ox9]鑵nzAxEX;-v8{1iPYN(  FL>iט?nNz$\~jeak] қ}- &9MN5Id={+e|BǗm,a>=jGG<_k̓|07- FNtE3."mGSQCwE4xL]ӽ֠XX>%ٱVL f?`䎟Fۧ@H {<G SEOִ]D@a&S"8> Z]y٬, ^)oT*9mwy8.`(VuSwXL 0/'/!*8=Sy6 7^ES={~L#8Vt5;vOU_9.8uD7ouIOj{{8IJOy[ gF?ȏ~b-nl+H%.Z;_KuKco[D#TmndC=gi+NDZS t &'pmX7 ߷ ~݊HbRnQJf@¡_Eٟq{yq3}@G[ֿJQC`Cۄ"+J==Tpx;9 )Hu-ӌe2' aD"2d9C~S_.P Ohַ![(r޴Hrq=4__ tQ-]8-SK0z=xR k6MN.L`:!$~IᴾęEI:\Տ!OlyM^r_SbqZ{O9 2jB6E.F}gR㧏%?Ë [\qviتS::BU5F&[ZQ.-Y'ӯy| _?t bs{kmP?T\@?t~WyuZ||o#s <#t;1vqTo[z"'ޔ%u#Y06e#1,6KqB *X#mM"bjy??F )C[DTt*VpJzܹH.Q'dr޲`ߏ5?rsԆ"@/j!@9-s<}x_E5ڧ/G1ټ)NuLdWpԃߌ"6m^~O;:^KHo@ g9F'8yZ1-nb(s?-65{@hZ5n?ŃWE,tv=r]IF>*Y;c9􊥾Vd2UV|> )0u;}?޾Wc`{JO:.X gֱR'ߺ"]6#])k >^΢Ch ^L#6(鴭r(;' }FrfLni`*ZBX;@)~kyoݡb[gp^M +A"U'(tlhxU Xƞ_4uB,5MT6RO4E;:`Qsƚ'bϵmk+ѕ~SDv# @Uu׌۪cMHJVk^>z-iJ9oqZ0ѽg4?jjA*׺.C[1>a^݂j ~ JB ܚрN]OyM<";dۢ'pYܳ}\*IAOOLiܾ"*]^gU9?Wn|9>˔i&Ń7K G0[q)-(-MHEV: B"s IDATwL-GtӾخj8jg#\rO@yBJ]aZDIR~1w1Uit} KS `߂1?E:X00w&֦;;+:;2)3ݧlev1y:0 (z?mP)c =[س+ۮPjD<6pZ"biUO.裪̷Fu +^>qZ3^n'8nhWَ 4akl6G}h܅CX[`*7*<K/?,9-:y<{6ЪQ|*nkyljU+y?|^PŹ+ȑ {0"1n5׭UEd~ƦB)?q'KdLqGPzb%}CV3D$&7<$ʥ$<馢Ӵi'>3~'xNmǭCȸZ 딱 wt=4HG '<,s" "qn5! vphrKk+Dml쒵{3Mʓj?҆y'ɺ ,~16kA*9j|D6}262]X3 ժa3L+pxH~6Od9 <޼J%ŬσHe7Ge_jzᤕL#{ӆ7ueL4={HpHb=֝ԁ]x`篞W&"TGqa{ѿ'Ϥ{DnWfj=lkŶoPSf0턩2tT`. ڹIJ &56`gٺr#TG8[‘I:8-|K jYM];DQ.8M:O:EOMIGXg)*N21ǹhqW   )S kO?ړ`u g3ېzn~Vρjko^P5zу~|}rN6TL$pO799[Vob^wRu~iàiO+~j.wB OzyyI&slkwØy0'0\`٫KTݦ\599lխyA%4J㓘FmmuzZ.>V)x)#b^f:.x (tн]0x˪Pї9 ܗCGGyՁj. R9ufۍv(~AR8y P.[$L_UGWG:Ӫ@EFNdY )+Ou\{zvɿ M\~ņFj@n(ֲ>4k@֣e3D]*6ήj5~[}T?Y|7C T jRDJ](dt3 Cxa5UŎɪq_Zl #%-BX4>3! ^'Ep FH;X &vٱ 'l4)UĎg:R@mi dR# Ӟ&+/'/dYqTcuysd;B:H5cMc;w:7"*2̄X]T I9б.԰OBȳvuz܇p .X ߙ܎g!~;tM5NY9s }/8u#BŨUǤimc\׆TD}D)uHhtCj%xnzs䵕im W7I`N+kuKr'a9٩u r/%dR^qk3ϊ'ZTgx(A?&pI{Y֧4j6L(*N'dBmA٭$9VU Yg"b-BIBȯ9\ࠦG)q=W^l}O7o#h܊ JcX؎ڕp+Z]z@aVuoLW֭U'd2 *j#N>3#jeʮu!`/%:\2V2W:]ĥ1^]70+6oЕI: 5lZ+6iz#Gaןoemrc!Jon`WˏTO]ҮПcmQڣ_ fP Qz8X} mdBę ii%QA5h-(eQP_S~ =1 $sNdK%̊Bݕg468(`W|A&[_PhF)ӜwT@m4 w/-kLm O?$fN~Vѽ̓K %ͧn`naU}w[ՎHb65t+ Q)X11sRfj'-+7_p3y~r*i/XoyiVi^~=?x"k ͮ]M CԈn-q3{ź]݈Lб=%f6%2;5f-.%{>G,9+p&{ݕc2w2 R'޺8'Ö=Fj%5R)\Ff c.Ol a%* ?R."k{Ο1'V6 B6v O(k::Q؍.}ŀ]jܜl4E-\qؒvȱPñNoxtyb4Paڞ`O;:{"֩^*BǖU>$b ի&yo+eNe=KWϐO?^} RtխEx>ݥZ \-gf{zsq <!7"4DeDqJbB,5UJu8:"|T;q= !~jKyciLsM|R%?aՙRh{\;J;oq3؞tB:[eKDGxoKU'Qj#e7ڶX`*GWk<@K7k7@"xz+'Sv }d ! rBԀɒDou/p/[91| FQqc3TBuOk)[tWLs*SiLTGϰӍ:ؐsubRc煍DwEc?q.ڃi=ߗת#&v JkfhiF_ZOrpy~^~v|wO#mylT;վ8}u:o-Kې zϴ}8lpA뇯,(MB c= IGxޝNP'Ԋ3J>`3G;džQR$Uf}Di*2V}@rOmѡcU,'dk8,Di90!rp+_SU'䵜-IUMO)uz߸)h}H+p]jypU^q&-HmZl|Kں \= ]Su%|_~g@W.'/]IܔtCB~q>>% ~Dl'̮ HքJc@+J٤u܉tTw"Dž]E ;1 ̴L*2NMoTh̕4A^gԦ3P[_qLDg QM h>`ihx:8ZrZQMٓN@{PyaJlGz{kL/hummՉaՃ: DV=@U-xuVSP!t^UԂ$3h_ǚEHu=gev>Dž-}̊ `)3N=m;>_;%r׏KQj;3['&BR+|f]7 ~jRΙ{Oy'7ezcX7Bo[`Ia^Wyk]+e^u:|saS nt SV10XDCs*h+9+3oZUU%k #;i-b[aliyx/=F*@b"VH|D~緥:S8uSec[ϩU+=ASՀ^C]XY|/'S՗ ì^:9NTW}> O*✦=PƋ _?T۪r{Z}}dΟc3's5uA/z]6ƌ5`Kulsͺ=mg%GK/2i~tm w~S>{ȽCNڭ[|ʾկ@uS>" c ͌6])bח2,!tc\Θ-oW?'%4c IEp igq޴\U&j_-vmt?x\2̬}=i=̙॒0"ݧU"]!xb iɱԃ0EKZJB-< xsa -9;c+CP|㿝rFKqmy`7Cu?sw`Ep+;ۮ?nir4zi v^A.uG܆ t\1}Q8[KUʸyb(;xx*b:'AkuqY4˱Ӳ5>!mn/b?x2 FIxRF'[?% :1;<"v8oY h:M'*:u' Pg9u;ǖ;ˮCWwcfC0 •k <9ZS{]Gi-k0 U$IsMxEڪªhWnӬˬz; 4nmaRR}M 2ի]`a{{\?gJn(J,b~0|?lEğ.V'"S6\%}Ӆou#h/$? e3Z*%|?HqzZ ԗV[?w[;;? 'MjeN{Nؘ 0o9M&RG}wVʭr Ccw WHɲ Q FSjSKvq_4->dm,ӵkx7>y6$E^gT9g!qZ>q4@5N`wrYh|γ9$u~-ӻ/sUud(S-у&A9g=n^Č[XN-t Z"mdU:' Z OX|~elTMv?cx{@T& =; [X6Ӣ/ aAN$EM@=K@us8rSߛyxXږ>q҈@t Ṫ,SҟWofSoSgJോ*c9ݑmG!U)6NQ+ƒwưv񉊮q ̞zc/V>??!s'lp~+'OQipy<2^+Ynr]0gx9ZEsMaķil>mɫlwZVR :)Dlʂt,u^˙hn_j<ʑ|#5 $^/v8 A f(OvY_`!R53R0lo<"fӇR))&kloTVe^}ZvrU EN [>]}kԴ9X;7c:`,]"yCEbN9ܛ3vȓ5S1EIWZSTn-dlZHb9lS`RBoH:-DՅK/`eA&+gk ].&Y! C9ۼEe;XbIHvTS7u!;>76o: 붡5vMA-=〟kZqH{-q>;l ލ1vOT- g;i_C:?+h#k |Nѻ_;~CdUSw&*EB%ex Ezg/AJۙo#&+FlVy (uݲ6Wru=Q1:ޜ݈Lb| IDATf$4 ~`W4"- ¡U=ΑCw;#R`~M;Zͺ\BND C_ 8#rNkg$imĄp~s.҈: `/,š*:0(`]"s3-[|9_K$pg Vm'۫4]џ=AJzRK5߉Ļya@J!ӪO2RG29mm1mMn, ZDAroJ Tmoi Q`!$(]eJ\.%y'7Se;)kI76[5v `NPLơ2Ck:_cl#NCsՎ\.sE 8wbIV,WO 9|BzPZ0&L8@KWh`ajЕ:Ks9lJ`V_e.4%jȱba1f3>렓\ )gͲp _h&U?O[ˎn͵ m,*_\*< x%PAHH,ƔS<@m!I V[*<8G0;}4ı<p#}˵+]Ю$l(yKKlimQ^ZV e .D/F#.Ωbz7ؠ Jq vvՠ=q 3$""k+J˾]#Fqg$wꫪ9C#`V%}!Uvl]#p/T&MLP㵀f?pCmvNS/{}ܛ_2-$ynN̹]ÆBJd?'hǚ;) \mkRX4!=Թgt$`?gE;1ύI;2voZiyX뼭sҝ }uDC`bi MSmNU"ZUH摫kNg ϤSߴYR?(i}2IgoHg`MGMБMN[I\沍nwJI6KFf *H?L|t2xE>y?-xk /`gqz6Ky"'}jH< ]+YlS{ߟxwwvR2MoܺUrQZnD/LP]co7a*jhwEG<0duDO 'o(v }*xb?e(j\mQBl% m; Sk0]0ؙؙǣbH5+ =s|y;Jhu:7vb)RNp~Z`oɲbD3fXfߖ>^p2xqwӹgk云߰fY9,fke ۰:,a a9,fke1a]l9޳:=:RTzU*(oȑnl_ dWѪ!͒6g+\0DTlZy"GxYWŘC#yI)rJYV ~!m#uxsy}:8 Ik7cU674rlsQp$^Pj }LV-36izP;&ZM>ƱJ!hwj«^k|PՆծ;#6ߧxw܊mz=` ׺n7s#}0Hzv:?qXfe,#$ w9-3gFQAN*Phnӄ>NJiӉ=G"64"PUtբgbGCY3Xn/ұ5M|V"^UW94DDdW3B¬P$ /Xk鳿}MQ7s|jlL,6 +kQ+[Vpǀ<Wghy%:+&/n9"ܣ0Uo;l6p)Va_mwE8mn):U]7g)aE[6<ΩySw;"?^W<;3kgkώb.븫F)X-cHͺ7̅Vc47s_JPV7T몚I(p ǐ؛q*F!9E\M&DDStNHxV95}]s)T~AbV̠7Ng=߭q#t,=<@٥= "7zaT^,dž"gȁI (r($"JiQp,^;+Bl9b! Jb<2 - @oen&njS>ڀhiDga.S!NьGJj}-q-w݆H|m۫%)̙m\s(Louy\~a= ,8dhS.WqlOrQ$$eODw>N yma(ɶi\;8̯߮#'w2[SO[ P1J,eA$.4K !*đ4:]u+IH3@:צ+;6N{ٳ j6C^+j[\bziE+N*5lצ8J 5[O5RgtC#1'-dPj )k@,S*8l wU$8 a&Mwɑ"d1Okkk!*u' 1&: #_T=cG J#;%yh8ǔ3) 1\6`b-v̬6FNm|d)Æ{_%O̴­19.lX5w}}Gc YFȅ=G㷊h#ML*!0k6{R^4A\[< q6_tӒލRrYJX0A+Տx->[fo*H!OeD@hR,[Q=Yyݵw5B-x"_T`e燜(bDIC'D o&7 U! uo{ѼQl G9WTtUuկSM;}@߱,*|#xV IIXa*WH;'KS*J"o9p#.5-tPt: %uf,D,EagA ;ZE& =4W=IL۲@3m6eE:O~HS} nAhȾsƆM[>o!bZk2ܻ@)qEA*%[T~VvUskf|saNOFb=QG$t1Y. Z:~+6R:Ah 4)}_Qth7}[fҖKνRĦsVS貙3 0'*Vհ6!ȌEXT\oJ@mM1Gr$`A1,>b6mHYV3Ԭ AF!ag;6;Q v丶]a9u(œ @<PVYM Áޗg(\[ 8 D?o\83r( ¢[P -%X03 u!0i\l?&FxExMK3 ƘR ۻ(T:n'[*+sY(E\RIg@ Z-T2n#i.#lDFgܥ5<A"V:WȾtM_ӝkBv8+euiSr\9j* !J_9|UrXs9Pm][sDtE$nkmJS󆓢QqYGH'ЍAz8FX~HP=n2',>$sH5̩FVWP`Wyta1ͧ)vF֏IY ‡ #+Y\ߟ\oHz\ _$s&;3|& n:?@!ZuV5t H@4O}{14[> Cb~ !#-Y "ǵ&uf.(ap$Xlr9'p&IpS ae`0mc$1楮'NǢy RvtX.ga]ob} EBĶ<{XEsFh=# țMITt1s^lq-Z4:}d!h|Ww)lģmlaІ_#3H軍P!ob 3gnt=qhɋ孫+ $lܓYExIVwt榕mrϐ[,VELkqՅMol ǥT6jD+&4'jOk(ow -+d8Y1/N*!F&PiܒJ ^wm&/QONSӱc쪦b좶 ?g"H̝Y+jQ՜AT*8YҸEx$3kcP8j#,RӉyy"{<6`q) UD@`)5d[Rv_X``0ˢA4FEJ6/j}f>"K{,lfz)X9 D<3"n(ՊoCFJC`R~,g"̺E,h$F=&ϱR|= HTshS( F]P]͏ Rj6 .vh p6n.?v8RP&x1u]iϪiu+0ϭxٯWhJ}ޔWcԎ&f M[*FkMf9u]NW<gQK80]!NIk+ A$պrm1TJm( yIlUrtdŖV n34Ss gay@J??@T!f'8-C ȶq E"p'KJMhl0]XhvVp MvkCDN'!! D$ot)CfJq:ΓY<70=瀈Lf;ݹ3W[ ~e *XU//i0P7cݏBv5!L֖I{FW-3)N11μހB2GV𠓅m! E5 )Z&ԟMǓBR$|#(|9Y[B@#G YG[ige|ɐ1Ϩ1AlumhS~Ѻoxrwrm^6PGwA2*6%aZՍ˴ő?D*"OKB좺 Uy{ٻ 0 T3GPj$]Dؐ]̾#Cvqv흧d(ϨPe{2fP0bjp#ю8ri @#s ֕d&(5?;#xI4 RVF=3!',@#ȝׁPtg0!()"~i'H(ǡrC(TX, ]Hno_m)Ŭ>Ni)] 3q)/Aa*=4ʳR2i&`!P)gf܈]e,Y%HV).2("UBgjUTNĚ 2s_cn%OsQ;g=ua&FiFAԓ:po3jP !h~·C-pw EM OEta=z;ei2K)C/,6F$ H+@A] r}rUg`$3Rv Zz3~p~޽7mbk 89&.b zޥO9$c#v)B:}{r׶cKH6%7c꠴4o:g=R5}v IB~K7vƙ5X`S|I/v26QzB/nSz2hO~b47)w~e,d ]7!2b)I 5.\ ϰ:(SmLmt"z f\_ɢ*NJeifT ࢇ3;JHצ+ gqNrJK"y(E+{5O`xqTΨrQ!\D(exy\@b:ű+MwSڴwfı=b"~  YcsM eF7F?vA* *Tjza^`*弮K؊ՓH& 8S:eb a-uޓˊP[S$raf#ˁ 'z͍m:Cna귶"ee&f[Ӭ{PuSqy$H&h[ZCCF %BLc $k>!]BbjK3-.n\4N#*֜fȠwe4|uNjDh  | P⪊XWhz"!7^'SFUIl`-C:N-m$z" 7K;D;#esOG'֌mlFn!GCH'vWp8oy#ّ cW<4]vUsv8 qQw w;;){n4i?SYWb`(y/gn۪@NfnNr*Y߆J"O4A[\ NOU%V/T$Ţ<5mJ99 ;4>z ՙ~ж58+4wDec:,C2ZjZ.4Rّ7ƫ&QФs\dL3c\6B/ӑ XD9H9(jiʁHgI1;S!DUY4nVY}ApoW{EEX ;p/;%+t&>Ra.٩X_V :\0WCBD <0@Aa;Z5Q^, h!Z=a)lkUIѥzLro'޳iDك/i*퇮] ?nmtG@vZ9\v*3^=~Wtԭ'ڱ:M iKJi[ NC"YI#Ռmҷq8c-B]KMۚr>/мG۽yvšl=<5]p FkNSJA(I>PQCڶB^%Czg=ׁ27o>V[BT巇_OZK3 1 71j=L 9o6[ ]AR abűHhVl#h k'lNkO k;4¤ s= .^BXUtL_C̣v\'|'f@eT4o^#4gնQ∼Kas'#*w ?QT#%Ljܔ5P!Y=*U@^@xCa! Cs]DvYi 0D#b$|( 6 頇e]WTp>az g ^n97&HxQWiU HzƇy^lFӨ8;MOA0Ȧ+dPM3pKTsAS T 5˲,|EXV3vڏ&&~աW4FH4,Y+Z3W)]z$[s+mvj8FL]xr+*>dUr[Tj8ۿ1>lFU9W~ξageGpU2v|"N>{+}Zi&&zF2s6泥.l0G:[X,,3Ҁ4[u}.Mi"6:L?ٍ^~l|s6pLe=v]_%9:i@tu/l̐MwLks.q‡|xOc[#қ$%YJe ׬4]6yF2 `7ġKWiOPYnwHURme~436:0ۇ`EPWtP%~ )bL Zkt[蔆rVSZ*yΐqRðl6g/t^<[yDP2i~(d {S&W٪FIӻE,IJj贮GZ{z,@E5p@7Y6bcqZ-vzIyeAr SX)BQ@$,fPQ01`3av*/w F]2w|%!TN{WegŹ:"`bv5| fbM7^8Uo\&*e>n;l8_ZQǾg:!b rXx9 Jౚt7M}盇OϛlLU:F;Jg[oF{OG8'2:,NFvbVEЇUDD Wx8g ,8'Yoir9aP=?(K݋|r,f"-k:ɣ&#Q+V4"j`jid)/R%BΌb=]$mYbAUɈE pC(>|&/ 9m@ A2@8H,($ bc\:gƁ "b}sjٌ1}v e5-#JZL?~_ &`[iN^g'_-3d˜ YxB^lXcC.kf`oRw-? B{aEKR4!B Pg2r2N͵MrJ<M(D6ر?y*$L !g7~C(Kͬ|Q" 8KSd+8{\'E"%J$蹵M`y͕dA yJ *HyX[H ŃX\bêS " $!kzw,/X.[TZW{v@fjG^ R,^ݤ,tiS@Æ)D}E<{ِoRY<@'VSX t Np;/!1u 3[C`ݲ5<*P^;FB²P,cLyCT@B7˫MAM>Ν"-N>  -=dڷQEcv[683B:Gfɶ< ;خ;75k!.iA6駝B;ʂX[l8짭p+cf:pIC}9;#^)O@{q9&nDHR.1 RUak$gG w3,Oh"md]h 55 !4o40gK%C3i#?~Qlgd-`h9Az!y&Ź`^Ou ~hiư/pnq@MtM^5@R5ⱘIY 82XeÑ!x>@{R'<3'1uM$.f)#EU"'9UOt,)`bUkY=ȍb D<5nWpfCb# (FLh g3S9f7d9߆!$>bzObyD2i.mNЭVA6ڱ_Ƅl]~[&"yN`NHflṽvO'{b2z}¹s,Jo06^'B[OfGXmCImoČn${}f}Ee!Oc g* 4;sf zjL܅/mӌfAA5Y\+~:xnqoqD"Y2eIFqA?kюa+-O?޾r{?'|=P7vª3͈P_yaCY!C5hV6)SPA{=Ư+;A%x׼oqX7ЙXx0t{w+!$NdCU\PhЎKR䓋 $8^mUe؏gO>P V>X+*? (p i_5A:3ǭnE/L1c!cFϘT*Z@#W+ f˜.6 ?PJ]hzbf> zyqrLOV<64UZc.vYyh׎-k *5E ab@&@flBUgv~MnNK\u,;$EgŶ[`畩G?u2db3.ӓ0'鞩iJzfGۋki l!5K;2oaVO'wR|X[%-dOU IDATu. .9ŻJx^~֕r`K 8!U@)'&"Xb|'Kb{5r|z ;Uf`}1Ha_ e^JQwP,B %K۠g.-X%?SigQv]WIdD@ZIhӫJHr53N .ֈvdɛvl4ю1F>lx6#{jzٓ[7fvh>w0vcküzvO,}ԎȔco& t6kkNհ)!5Tg׮Cce5o\ pAi0tt]a\?\=m=δ }j=_j9e6"q #gag Usd̬HrMjYavUS}*˨^GЇ???~_B5#-x)}bPTWyXOi!ֱͪ.3 d umFt!ٸxY0^n ݍa͟:>7VϴPbRxw!Lj`8F ~)b+5=OIga> m-",Pt["1cVd[JwNITR hcdzn)aW!a4rKd{oAB6Y<)b9U0U嬖3Ɂ4j'xQbCG{Vv!X:eV5ӣ737SU5duߤ-|[ m[qNc=w `(Aq~BRwQfK# nt?0m"ET@s@!!J:9 JH]Ƞc$m>k&Mp#<~ި!3KTynAfEDiE#Լ3P@4Hv湒zr~0Hb}4{vؙ`~_xH3k^߽<^xP ّ] pdj'/@Ga3 B2C̙݀4Q-_̜S߯+OlZ;zZwno,Qqc]YuVd'FY lVª**3jWx"B {Sc_wٳ1k<403dYfEwSt@,FN$8UBOh=|dE$}.bdzPwcv\Ŷ$L?g=r2dzl!>ƪAS~:>oJ xl?jcN!pT=Fb O{ M+r^AFȮf*ðP0(h%Q\*DITLt%dX)ŋϞ=|w3}`vfy`W …K)ݯhx2f(M,*ylbBW0DUnԨY4|t))7!_hrC'^N4N+ڲ) DA >($bϫ+z}3Xĩ<|ڑ3UwAR!DDDu=8D@Ыbę!Tڃ"4$ 3|DD1&h M""'&ic4V9E4|kvkBgȁg^~ڤEvL1 #f4{S0FG٠vVO̔Hm*[dRF7- !crU۴mgYba2佋E|oux`߲6ع/mLG] ّ(l'S0˲9.H?3+(nf 4{Y_5tnj wUDZF3PwÉ$8= @eS@dH;(.ެ0{obXi,~F +77G:#s0υp .3@uf"@<"sOZЪn^y~Cu^ǝDMBEdJV DENL"7e3SҠ ) r~X+bS#$ Ây 5Uݵ%նi8Qk f/p0'z4,ܪj.i%$uJ"PFUtߢsZK5xӓ)d+7`OloVxiwL9/v:Z7?H%'#8={ ܢ"nL>4TX#i=]!3NfT]8]ځN; |2 XFYc4"2;~~^v " %!<_ay:lr;*ݬzC=F6Y%6MW] JUMlyꠧᏦMuy`E~("\#hf /&inb M|9k|j6WD]( $A`EP Q~be Uԡ2[aI_&nEb(b:`қl)tADAw">ʁb9d1T3h6g \bWz7PjkcD@P|nkql.c/F'҉+̐bMjah_Ǭul71r_>!U|33P>vj({%3?n8n u{qv2Mfv;>̊'&[\LC^|O'^ׅpBtr9t8޾uY c&ȱ$jk"_z;7m0l:ClM}=VQ vj[чwcrRwpdZ?Ǜ7޽'=WwwtsW?v}a Q-]/ޕ镄@ (444y~j)1Y'w8E0h-5aĀbBabǹܷlf. C6A˛RrDURR@?YWoDA!d- {u`| d _) riF!E$13Y'<{r< 45>wNOEBe!ց(j\c[Q@I*H F3X[WU 4ɫoHf-96~GНQ͗[j3 mt ]w:5(J,();j1M䘜&f)c_9(Dg 86OWf7ICaڕy azpx>=UG:=no;[\p:^|OhJReuP鶿\[U2Bx"閪$$pAd ػ0ODaJ)}VJ<^}/_~<+r[3eɶr'&@3gvU$Bg0_~кYH#:$"9EQ y Qb= RxCC6[‹xAcc'3I*3YC8f#cPoz/l'Vi2HԴ ӃlgƏ|ѮYB|q/2 V" Mda)v? H+kc{>c=\E6m?Ke`ҨDbUܰ,1)ÿv Pl!7Vj$?ʘS7ư^07*[mJC. ^;͆~H0S#%=iK4yl!)ɷO߲edm#dr[r>u"a-{,e$w *-#TP; ؞H#0VڍU(x?0NI8w:͍yё ?/Nyu n}#C: ;v#Sʆ 4UJc,xNA1?(%qPNSnAb1ԧ'_?/n8{xs[Ή5CH/po #zzXtte94ǥ-qIkV 3 ر9IÚd4 gcN :H4h<@!+S<չ; f:߶TVhϾ%WH3;6ۈ_]ǣ.Ʀ´ӊ!{DW zbŧ{F-fEM){mBꋱU4[ɝ⤡.b2IY^%,^ ;RJl1#/5-jtJUE _˷߿{ˏ;Pq# )<@-tmu,8#OsC|g@yyEY:w!2o.Gl`6wklƼNKO*,Y?\}wMā09]:СZʧ/>a/sGs9&Vp̷t >ˇׯIө!t<At:Y(8W,HFg5~-n_T\הlMbpc7+8Ey54LԹiW2T砧b=-~ba@chю]|p{w޿v= ÔMf4|Pݳ  IDATA+,W x}7h6Uh Kmp j  ) W⳷U(r׌8] oԒcb!>t+(7n| .e+81檔[[CR" y j|r,m֝i!*EV1 =Ek1KuavG,B<"+-K0IJp)ȄB+0i:-Y8&IqN}i.yI8#D^%y&qzgCb\ue wy38M碣Hͩ|.:s4sqҗFΚ+uqL~[gv\'}}x<&Ars8DpwKTno߾=xVKqs[,/q4I2#ioKwYu=E7ZyY{|Vh_hsI D|/哯ַݯ=Pvw=ҟFдWRK&L $aڋjfe%KK%3:eJZLS x'qlA̫O!G b)P 6P;8ͣ.NG`pi`{{Q}r^Y7&(N!RlV +uk'ge;77pJ )11!K\QH4Y,H{APk ǿ odt)Kȹt6Bnz߷?;>yRϜwi2zj+g3X&<}޵Qi^w+6G{-CMGZ!YNEհ٩"g6\Z󬤪?SzލX N}UUԍA~?9Q9nCA9t:>~[`r}הlp(c$wEh崒֖:B$*IrQRӛioEn*•bR#M35/:LTCUjǪs˸%;Cfsg*>'O65PaY̵r8!jڛVeAO)cdJv?(-&J|VE8]641G)J̳@tr3 R,=1M)TCw(,8 RS "ī}r*==qYMi9-3_b"_/p$l‚zފKu@dQTp)UMa  ܾᦓܻ?Vv~ ub|?i1[-75lax?,o,+|M 8LPeU5)8*}[)ȠK*93_ɱrZI!ߦV9I 2Ϭs?nـS&Skj^Mgpol<'z < ߿?VKS62d7ZF*>U̝#[,/}XQf\Pٵ|[@!LX\e[t `svwS.ݲ|JD?/imo֛)3@)+^V&vK#Krr9}qa:9<RoЋĐrzU>jҏ~ g E%F\!Q\Wbv1uT_Ks"a"1 IODLe"' N1qՅ|=#s@1ʝO "GpHNHs3`H1071Sձo-{յ;KwݲS(t*ڭp*yDXVYzI*(Iw~>)o㶓Y\ Bmk_ޏߍ3*i;oP66r՗YPuB5k~PՂ~*X-^CJ5$8lظ:i)P6|U{&- u;s|U*:[#4F˟wtLD3~ rW/tGɓlhvpp88f^t~qٛe ӫ j nO{fSiwyEx*'ixΈX,5 Sh솞 H;MwF~%/Wot1_ Dwe6b(ch{ȭ8ٔ0z=1DoHVuJycQ^ԹLr$%MK:E8 0dD%/Akƕl]8mx\VbހN=&ظɬ iDf3llXoj=Z_7mBSL蒫 2/8Rւ.iEhT (T)nH30`F.Rx)K[Z<]Ǩ2ڮ7HDI?*~Y:R|1XNAgE֚y|R<'8X,XrRW< )ĺ.VyQKnDF#oY퉺F/i^'P|Dғ"}c.8:@͊ Ep"Z(wj^5bߺޢaŤ Q4.[ȻJ ңQ 5 \8~b3h:xzX} 0t]T(}0aawb='t@_v@ 5YTD}l籲vjF7@z˗wGGpOWWyZuf! i4<WRɊev&M._XQ_06yHft[r_R<ȩ!*8`^Gz.l9 ]Z&Pn+HVuNIIEPnF%fg:0<<,@aoҹvX*2adad+ "!D2J(6%P'1BSL I ˔$e+ !ťVHvN H٥q^,VmP(k[8D bBؔ-P3q 98.QFDb%ԤUYyJP>O6 v}) $~OOÛe5DgRS>5Ҫty+ʩ|gӵwDeG9t /jFO;J ۃZT Uq){`qږR<<}~><8\._׿~` i9?|-*[X5؅ϖCq׽Pղj| ua~7+к1KƼ8]tM9k!ə 9wgFrUq# OO[DG'3V۫"NɝɁ);0ټl{/Iun_Ybk'+!ԜbD@nzC\Q*@%(B |Q E+Ae^ 54HdmІjfK{5OpOͷi?c[l7Gos#0e<ZE,@_r M]7\OӮOR8;q Fk.v5A_9U"BP:Ef%΁n-HT*p+.U[霄5W'=ٶ%e_v K ֐!H =?S98vtaHggeda)bP,wy;i+f%wЋj$$DQ*yXi&v*mBfQ-'>IUvjy1aRj'i N>Yw9abVn.~_P9T ,-fGvѬc cg4ifKvtf;QmI6}uى,v/ʑͪN.ڑ6MQXlͻO'G.>~K w7_~1c7*Q* QIiHTEj?6X']Df(ƪkQ!C철ZS8!%*\ Rx-x.P%Җ@-+ 9 ?D%nQ\0fz"./o6btpt?;=7{>\_}=Xٮ)$'&_=,գj8]ꪳ|nl C+F &q "xh%DȩT*R13(%H`&ZB9CoA&X[f攜9g߶yrɕ+I#DH" ӓ|h U !TVh'I _)(cҔ^V\ftհSc %.a?ku;ˏ+duVu LVSDW8Y_Ά c2.m1Oku "0o./q.}~rE~|mXV)3t{/z1tk!*7pCԄ EAӅD1Ck3Vo==}w__]Bxӗ^JO[g^e Fęy} 3R̡N!1 `QnL ;.&(h46 tݫQ~NWڲ<(YTo5ANR+^?HI^  Mpoi4UA Pc4oTK٪x6japՉ<26bXj)5 Ũ]O+-W+)Mi9Z*3b"c`,j,tuEGM?/7_7oBv9VˮԳ5K ^!p~+{Vx'GD/1"0p|vx|~݇y`tIsVcCϾKy41 7u\嫔bKI!9iޡr)͛[q 4Q5P>blSdbWŖ|U/ zuu>G1-<{jo=;ט[ƂD. MϦg2ɕ$@ h y. IDAT5 RlTZ`Ūٙ]atJoSPf-4Upm@R l8(ȴNF:i˔iZٍCVk4g?]b%Ci3;ESӏv3L}1+;00"*>vBTIU`Z uՆVX2{0:UqK-N'*_8 F>c2F*X-sSc0D^:ў*u:'ԝOiL rSo`"cxz|]-xc~i K`>a-ka`leS6eSֲm`Z6氘~,{yIȲZ嗧x|z1߼]]_}Zn 0"} .w6ʆ"NW W:]RgBrmI%yO g,$\ Od>j,6;^=>c7 86 /3ma Dƃ-ņD*Mq 'ovz8L$pҩD?an cn5XȒ48ֿxVy$p+JA`% `H$ۋҴXHvh4m`r1@c糷Oovxr 1}Y-PvQSop,kGql_铋Aic¸pcOp(dP{qB:"$Yd!10˭SO܀@h\Bcjq ?y$Y {RZ'(!pb{>ܫeL6>SMU}Qb/Ei*.%՝ hJڰP>5ԸSdl¨E Ҷc̯/럮mx4<=4GOOwvvy}=;NbC}T2Q4=vLM4b>xQmj*2oүa [9kصkWfWծLlAdaU7Gsæf/`gRp5s_^D#opecA^I[s/ddJF2d?dsH(cPnIXˮ]ΝXG3AmY!4@075#9x{dP $@PgDPIt} @[מ̾]&''Z&;?޺Yn 1m8>B.|`Aֹ?dMkI%bYWw#k pD8 O5H1 "yjOo7ID_&1aWϻ+ hqKD,ks+_J9؁4 P>׆@ӔAyIQ[FhVWg~ {;:W7z3̃$Eҫl>H7@%? cXuE{FʸכKS&{YDas9/pYJAۜ;N䡞ͮ.iھoC_n2nח߾UWh$ڧo,60T-?o(Ϻ]jr*ٯHn~ ߀V%n]u-sL_bωQP\, #!BO_pr$o9?yx|dH"tB@v ӄrJ|gFlvn{oe~jo܀h80lFzfh[2׉O\L\8?'/(jlԙ?;^ɏHrV[]2 'C%,fB _2XtUe+4Tc1Je1b0v~|rchr&mێǃ\ICIJ6yMħ C$ ߄P4Af6A"o ODZ AԪ(K T̎ # kT v]=2]GL~,vy0Z|;s!9ahY/T'MZs-k|"Yeͳ|`2H." D K+ cnj,ժLF؉rV\UȢ%b05Ū/_ YTiY+e]WZUFL@Jdێt1>W5== IЩ832r{UK&S2~ (m@/ֹ}Z,Ɵ>1pvvZ/N~>v==M`B'fR/gLXp&,Qjۿ}tiKuǨ >{/_wQmU8s%%bY2+5Fdi] _Sb~y\Ӹ C3l7ۧPwbGպݖz$uV4J؞Yx#=U')H7^lI`ɐ4`w:I$%mUTId#TurZgܘx7:Mo?T)[m6toǃhi;vG^LdX>a34{?(b[3[8 A*Eٵ#"B=^B .oΧR[s8><$fŷ+ G )CPI7@l%'CφvhJb#gM6xgv;'Dy,M굠l47 #6$08Smdby4=#}5=gG'R*n׫- [ׁpvq9??k#qb:A̠pG隟L@YH|0`TH6[K7 'ao3z _`(C矼 vP2$C!}XeuouFzi6\̄칆[`؁;АDsd@ Lj[CnUU 7K2s1IӇ}R@&Ϭ>Τb ԰`\E :&] G?AҚm}`ev!k )_tNПFf{Ќ} >3Sا- # }:.._6фp<~}~l7frxzpiAݷ{PIJ:Joܔ?t6BV *{ڙ: ls}{t<:xWDeeJ^ؽNsZFTs)d dDWzvH2|ι٧aNMjyvFxH8:R*,.([J=<}RG`dau9+—^pňZjl=(̵Fb"e%+W |inۗ3]~[NF7]{s40}yu{5Dg! ~UFs~Dbī^|Y0r"LMsc0:UN+݋?d Ad8I9haJָjfck3Q3NU@`/p 0}P&:G2J|HC(""p*)TW IzW @ V~ _JjtFgՙ+=2@Z/(q{tv L,=*vtx?2.[ɾa~2jy4 7 v:5'u9/wXFzg#(Prn[ˇv|9|ƝL^]ؕPD :Pl>aJ!JbVuQЪY{ d!+{'|6Y/!=w&nOX~ֈL*I,3v'ߔbj(QiQ0rֹ˹ܷ?Φ%]/\w/|tv|eeCF($!(O4\K7QbBS08^JG_\~`;H^.#ōX?km_7Aqbb~myiv#|b}w;=z\Jᐏ{s)5G 8 _dԊ݆ 8ܨBi1gw$SxX,8væaC`22z$Mk >#@$IRaB%3{E*9 sku+HVb8ۯ*JYlKfOhY?E(T`ɉ931TnғِLϭ˭Z2阥L֮G'Ԃ2F'ZO:̈=],[m&nKKزmT PșJ4hɾ3iqwix>1@v_O>Zg~ Vk<>9&X:/fš 6˜B>Թ%z?(dO\z>X`M_#޶x߶'gtADz?` %6[z;ҞgR3|?f\\|g߾i`r]z=z&4S?F4'2ô/\ 8qKwx87BR1&q*=L*2A-gn a*I8E>u'l6d[/ϫv׶b4iDH/LIm@@F)qNS8룜%3ۙdc RKY!o "FW lb. 1^o;Ui Xvpcq&bu< =2UvdeՁjjǪ,Z2(,7$ M ohV]D݃WtȊu& YkɿaZ*''>Ka G롱ҰL2Up[U#MLR,Z*Gws19bZcP}yytz6' ǟc}y}|Y0}_QkfA Τ/M ,2~(f;$N_$gfSjh7Ϳ_^==STQ#~DRJn ^%%M_|شn>< 1L?gW X Zy:p[ׁEv8p:ցm[Y*[GL&?pI&̓dxe=?/% ۋ͗H-\cPOJ_\nb&{0<0$Á$r(Sr jzY$.ˍMf:y!V˱6"\O J]*xn_`|q<?EWN*^9"EպlMUw%/;.@qII\tt:y108dZr 3lt47p#`;^%X`F:1lj-i10ι#ixT.SG2;BLcJh7τbjpw/$V52)9'+Rz-ZMkQ݊*pFm}hX?ShtWStUy:s `ȊεDڠ{Vf:FK5Y$I5d%>%=:Y[H^XE)ų|^\_\;h- Ax|>lc{tcŇF~bd)ѵ'FuRtͲ2ҊP]PvuoOSv־>>=[fm߶j]/H03% 0Nh6jAƕ"l֛ooMNN'&a_\z|2~%vD($PB [yoڐx%5a6F%\)a'pk2CNM,ȱldÑpc< IEYA&ִ4V$"cyuuv' _&bl\}iRhq#WmO]k(>Nwԅt0J95Al8'(lC%DX#Vs?ʐFKY$|u [C@yPv01CNt3bm$DؑYqy|v?DMͫ*S'UЪ~D~o=$@*_*)* }K֧ܗ=fٸ(]+a0dtu)5Q0FCMwoz nq3G77dt>Ot`jRSpy2Iтq)hOQ z^$Z,zgNFnO~H-c~ Eʇf6- z|cQ;pOJft1UN:qf{{?}_Ӊcb_ Oufi<?+@xBul$)ބgwG)F2 Qs8mkFH˵訸qd±+vÇ-~lJ@ۍo&O- d|wݎen/a`Z\KF]O""ɵ E"8 F@; `_\!x$رii5Y@#?@W!] Q1+Œ!MLBޟkH@9^ݑqc;ch4S(ݬ)y /fǞw3U-}i i!< HUy(R`)wP3hH,Ɯ}XU܇=߄k\4U9 m9[a8B/O{|裏'#6=lvǣɤm\~{X:8eٽ: %ZerU0AWÅ.w5d-)O}"WStS17bH;0B.F^:&4uL|+hZ*@SDb}15ѽJf 8MvEY]IuHz& )0R?adED ~-zt|.dq1$hsM9Ysrj*tY*K F׏{@ߐ—Xd몝3m^kko7:=%¸_~_0ؙʨh2kQb}+rL#}\?2OazpͶ_ڣ|>;?k|9@籴a h`4Mf['jjF/)o~ßNj1]p|=.]W~'kw%؍Gx/6)OW9~VTK*4tpӱU$39k!e$'ݟl<~FW/.T3#(?v: cKIC]MfXPXGI,øTS8 4-=q|MpX8vox'&r\m7Do~> Ey kҠ -14,S)?$hD Qx昉 h} QWdᝣI8uJx(9b8og$d2b%ZnEY[@GBܮd@̎)\$+~PCz=r UZ2enoa8-Jt5Uò&!+P5)Y[[n#ZHF%;RWVbJ[CjԲI7)e[l~ݸ`߷o-7ǃߣ*ι q:o_^Vbv'J?qL8 FԮR J"YĬUTkm!²aoY}=e*U 0/Y8׿xض7NiwϳGT梙n=vy)AxьD\9xsS&,_t|?<<:LzIdb@<Dsd, &3Q#-ƎAºR[f')]Z`q6kqZU4 V#m6Q)u?O7n䜣h0=d$X:tX/ݯ/F1^Z;fY(r "ѭ\#(qY hg#,Ba&q0h? %u(X`^0Yz|'AU "L5w:~0\vm(d. ssnIד`ͩ)bx󄉙.uG3T~,1.\L:1pI՜CIEFpdZA; 09j@s4DN :$f6M~6SGip Y?vY78ي X'2Fhk)t43$~F5*L:%-z|4]! d%AןIŒUdxdBs>X;b||o ɪ v;^~Q|=Z鑚ͪ/WDd,ḛ9Z^9 EVUS|Lq ?4ѝȩa`QU&lT}D w+by@n{dVuW JNBzw189nmAi:9Ǔv2_]Ń\;ZF:3UdR(_ށP(NҚ?aUfodr}Z2' \Ӆo']50TT.E^@F_Z?ű hx2>=\~<ToR m7կ .$Bt8֦KתyӐpOiY-W>N=+Zc AWIQdsSWG?f>@޷om>^`^(C~T _0۔[)wj 3I>_&sp}||fǨΘI A9؁e8GTMm9x =Lru J`9bՀ]Dݲ+"fK< =le*إtDHj.5Ô*-Pڜ^ F R'r_JզF&iS.Phlyݜďe|_%A;CSƫG9+!-]}J#P2[\x]r|<OMg:xz]-3zA;xmM[#d$[|GNf6k9oϜ&$Sb=cI"2+TPE# q!&+edBYdn1J6S l{9*Y'܏$/]g=g*rZU[qK26 emG9æZaROD:( A6ker~sSo0: \~{p6|KҦ>=_OZV`П?>fҫTI t%9l" mŅ@%%Z<,ap2>J'a`oN=TʯgO)͎xzfPQVRhmR޷MIdnZ"P:Fc7!zz74k2ge~x_[^z$z|7nj@[$eP}!`X, 4 6vϦLAf쌖H,vL}m61viJ,77~H2{@9`9)/Ȱ;/@BH]j<+!p Bꦿq~cR'W,靤InzVp E>Qc,.At@(k!He fd٧ 4ȶͦ%H$͎ .eg F؅%>50cK3ֱ-c)kYSֲ50e-[3;|,k{;[eY%ckϮj#rսG'0WLh߬5Ip ( 1=\4V{ Tx 3]~ɵX@Ұhm'PV2A0l96P? \Q)4S E޷~X{[A2Ӓ`:N4K]E&۷=[|bM;%zB<"֢/ 9PsYEJ5(x"BlcM9+ '_{;X;|XZxhhjEARݳsatsQv۵_ٕ0UPjrxZo)orGDE|K,)r:`]YfD (U!1Jޤp_JnQgmB*;cȻmʡ=S oBUkF"svZOeAE^YZ"Ҁ%fZ_98$1@3֮?d^)@aO2g d &=0d0ݙ8>M(_rK)֚ k9{׵ؕQX}~CQt &geFWR=ݼs5nRj "ٌX|Yg"{YB&C5I';Řh+ËmCt t[- :V4[P){|6)T_O=HM0Ћb:_OV7ˉp6(g`\:ھyd5K#@\ m7}YbeF"pfwmPtRG3mܺlKG^7MsYm^|&lSӓa 3tbr+~ {Rs 23fUv Xl:X__.fT5@m1IA 0B!Nc?e43MfXE7$]}up<&`s I1&\M@ bk`vxY:P_ړO3wG %*&~#6E˱M*nRVh"APm[.f}3C{Cgʱ8@ŵF&UVht[ Rό5KXkpIk0\,isY+e\(R:ttE$€&Bi0۬pr3J)@iPI~(y[ gkQn\ 4Q 2b2IDuT% TU"4K( r:$'F=sO%ae `fgI*Bőf;CP ?J敠'IAM#9IJpfmUtݠ*&?hOt6j&kp9tI+C 5 IyQ&Ct{[v})c"#8!&)\Ŵr=Z=mn-ʓmIBrOI)> PdZvrvq6 ~vRIqr{KD!6 4u8-X@fp^HwHAw3=&.C5r*)QTrbU\ٮ=Tz_/旧,"ҡ sUK%6`E )s{35 o1"@>(7@dX.}uTJdSPi]vg4ǚF06w~Pphk-_A6M qX?w8cC+1޼ހ D"{jX̚)ۥFr-kG71gET c6]_S TK$TX&GOR[BݐR% ~:$]{% E1juji _kק)Mddqn2uuwq1?uwHz4P뫰;Ýctڶ7Jl_iVIr8zۙT ʧELyGz',nv[MDۤFҵ|6h`H$ rzPcOOW^_ 棁(.~<~~}$;GNnCA;ީKAeLNKޕ7ё$ &nffV`7oUiQᘫNW@]>E`Y<܄p6CO";!К IM 9MGC#SXyy,.6??p"ob$wog@|y^,z2J4Ɋ<~E$XM&9|рJ9S,V4=wz v)\aH 5&K4fs\}9-O?,Y3 iS8(P8ZϠM 9?rg3Bgp_fK4bey>~v^ d8!2:D>-Ø4x'Cj(l6NQtev3^I'5G" 8wr8+ETw^],ȣ'v:e NyIo ~D%cI1ےA/]$n^aYAQ}-ίM^0XBx7321)ܨ`x; Mv|gӛMfPLWg|++f/`'Â-NU;ZJ\ Z+(U t[$B_Cr.1 \dJ2MGYjτȉ s~"`2Bv퇣tf+oHn7٬oףѩ}B5Mät6&fEAj/Wμ~vu|ݏ1~sHoLT᎘v\1~<g߀_-KySdiU@rb4XI8 Z{8.fK dp}5/l2>eiRйd2iYۿ/%;U- 3GS8b};z6ת>Vu]7EoEmI]8)ǚ #۪xRUd }(1>|X_M XבHXeu9_FTЎdh|}};gJ /юH@L. DbD"&[!w׀QGe]!ߺlJb(Y^nFFcDd]OSɆd_n_1vUT`t,uU;XIʠ]gl!fBxʂ8 IDAT5\\6RغFk.ikYJuʽ9=Y)-3!#+7U:Q:}`vM=I}mxD>YGчӒr-摱&]Ud^*2(JPC jB-.P4mBCFlfû uS ._7`߭G>s(n1&77B@8ӳ^^y^\ޜ&i+--[ QӟM*ۗa9\#e^)HT9n}S|zA¾_zWpx[.  |tWEx:_P|MP8RÙ/ R/yy_jH:~?n7nj4:X $i!gV TW>' 0 yPcrI"?]kD(~ ؝ESDVȸ w8ҚRE60 mƒ9g1wr^s nbP2^a_AɝnۅO܁8(*ә  P6D BH)=|m|qo67T!di{=T,?pӤB򫻦|x?BXэъɰPggӧd.Rlr3K%%rѫgQ_-.MY4 SI?4-h$ u!d/{ *DY:۲[F!6&` T~Mn4_(͒)Ƴd~g:X-R19r`E.oB롭 P bv^+vZk`s(bByq᧹lQLB)fiEKRq*ikSjM\Z,r>TlG B*LaHOX)Dµ;EbhA> MT\$Mn& 叅 c0DT(,x؞US ayj+WT0eR[gJmS՜0 *{ӭv}+.0وG32WsUGk4IW{@$~y F1/be.KX}XjVC%,a5tYjVC,^a`^nsﲻuvh$I7WWA8dyzyZ-Vm|/5$u6'-'G `H:  y`"2g9ԝŠ`h^Qsgq#x xde1+I4$hBp|({OGPd'q5ރ*rbkQr!Rc1C1/Șuh0T3}gR b.R{||{PJEvC_pX a$G)(Kl(Z8jlQ/EŨT5C`ȝ7e3ju8ڕrͬ,<9ڹ X5 7v*@agbpɚl*eq꜌. V)))ea%zb,nvy}i879ĤzOg䧋3KC•$>'sJvA0N䥄"<V/bptcuͪF,Jly|F Azp4 ^ TU]?7onPvqtRG</p;}٬H ʩw_T&|Bxl#ac9!^JoNCJKvDŽI/_kT}TޠקΩ7<߫,Ob~j1`hVx]uMJCEօ+3${q?I3t\Ϧ_  pf1{Ats Eu9`H:Xjd6B$_%$92ќ9,,FٚþGûI9 DH{ ꜋|򲢏NCG>.U%Fq6+9E:h@o"6>eSktߒڦsF9[Aɮ. #=`LF#\]>ɽ܄}I3!IONA|Cf޲vk=Ì`C5/Qh*}0{rY:(Q@KFf׫iDlR>VU^u Z2O9}z~"yAdӈФ4KT R \ȏ^KQņ_r"}yOjy;AmEi%Ǹ]f2Q(zx:W&UGRO/ 5qў]E|?y<NgWxyX?^Vi>RwG\`q'w{Oxn X+l6#@zUzY4frтQ&L7Jq:޷7Ұ {ysd7R%FtEE9S+9 `=~])}*~)*V Lɏ$)!qƋt hp_R'<. `6'@J1D`f r:"7zwoA#ϽGuFM^^[s?%T˵l iEdtuO`~?&g>S`"Y2[ #t sW)1a,PGfȬ %SuIz"q;k5P?XS5X𲺬#SlhUn>@. FL4AcgD)"l:l b.:wۭv`@n*ueɢ.FvN$g FeKJ"'PRΎX\#CS5 ػyy 8 *F %[8ztx\;Z3`wc J 58F-dž>Ĭ]fX{dpmb8.#/j'ةyY07[Zhc1D.XWݒ8 =wfV\@'c$"DE,5h2͓.e|zߎhwN֌nDE eyE6t8riB @(wptgR+@K q2x{KB|O}ѧr'%.Фyg,]ۣ^gxߜ.toc|YC_' )^,[))/߯oֲZ$5_}:WS`5lC=]y բKN_rt]H!֎z$l< NZ8#{ts-P?=ܟ6`0fr9_s, Rt+"?'3yYt;یdAyYOi] %4hլ(P]gu7d0nJt0:<\+%FmXq9#`]iX(Uq1I!  "egJ0* ww i40 ֕¬)92O=Maݑ5I:GQ'CdE oe*J6DpE"VtXMؑZE]Ղ׌|qؼ(`tA[ M/uCX <1pB|6{?Ti&ujZJi0*GU/Ր$H;6ofsfQ#O 6ٯnxpX+!HOy/t'? =aάjd<~QMy qB ""l1hBj!yH,uiP6XHzX`h{v~O㖭Y+Z N_Ree6#|-v(Z=/Z%ABg9$|uxTduSwV1U&#ƣF+:#7E5D/pV ß58T46w,U&7&Nв(=VR?R1̚I)fJwg5YQih,V:;u#&౤I-ny8{dž=e[!d&bE5S-u`CYTS)2ODi'LS&! arvַ[;T_H\TW1IzɑĬl B3!eXNFC}8fgd;N IԓDk[ďЇ'ucZuz~O1:ɡٔt)nyE9_*d\z݀@OAţ00yL^ 5YC^}9wKFNHq+Wdb6~ưƽ_\ *>o%5Xd>19Z5J:"#oSL6a4l\&ї?:4ÈG,>_TxR}v >蚻]Ԡ(R1#m(n7TmbDJ\Hq p&#>v 6T Op hO٠1XwDb7 IN@TtIU^K7A?cGbJ Zr8 F̦ ࠞ pXN$Mfٓ*i3glc励DAfJy\Rϥ*iH&wy8*0٠[dy7X=#q"D>m?|_ `Ww[.W-8hMʇ[)F2fxCwo0l|j;57AQ1wck5ADJ9 $n'_}%)bd/[:H߄@w!%f^,L咁p8^=W)lό-^Fގ&r${%-$l\`0l7mrN6W?Z X۰vr4ī]̢%~+xIhךݑ)P0%RL+иTNZ#A9ʙWۻ 3_,}|h=M.`4/d +NV̵L/vڨYoQ1#eAMz&N"S .؄X.TeFW= gmfs?2J`6796jLm:9bD$Zn`iXC\(eѣBYԆ@9?yc]lz,)˽xl&u3&m{ϟ7+CVyI)D5H eA*Hd7_w'iꏮ giyX'lp :C9q`O`PGt_uw^?]IVƒ]t6(04Oɟa>:=x\ &od2\6ђDf^gH6[XqV;$ʱQz0z~~^]Zۆ P-_^l6{^?_D*ER8A<2"â`۾}6v3LO|z Lx3"0>pfu3>q;N')4^ӣ{sₕi445ZÞZN۵Ǒ+X 6pYb85%l 01fnvLb*v.h1vwqZRWT*R~A(WX.1AXjimXVђ"gp`8FsAs7Mw{mL0=# tJpƉ"ˬ3z{mc;-uxK|I9y>?w0sML>t;jKNzt !~{<0X?5%K G  4ch|?A7-:=&+6' M)'7 RrYz+˝u.unibrMlp4so2c>9`v\\QJǢIаv΅|;ࠓT=|iI5MLfu9 >nKAtu{sc߻KqOSlV?I P5+k./b|LJvd~no8Xz k#3&O3@r~dK}os,d q?vYs@Ij7#cj3ؒѲ9Q-";3=V1;F/.3#u>|zTh{_Y?L~5'RjyniPO)kP3K9yfZެ݇gt'|E=]N0>d8Aө7S[a=U,֒Hkrv)Ok{HMH{ҿ>n\nWoZfm+iʜ~)74=cxas|mʖWRQo>n7Ki:ZӛZp0&8#1)F1hESHx﫪{/$Dਥv%"-Τњ#f`UU* sgJYϠs5\ dys[Y"Hil!M&S//{îZ'm!! ) ZZ[ ,3MeYkWڊq\n{s@&.ؚ!Th,l͂n̘&PcK5@`AZA?Y@%V_"U 2Jx0u0&1H4en3R^K0QtkBi#3dRp.h-g[B|ޕ@VVC@ȴl.QA52PK/RDs끻*E,1Mc_ԹswR{B`m4369>ZIORX Ξw>5>@_.gJ-8ujc): ZnhW0( ;*NY_ sy j%,9HvOc3x 0п!VPCG&\^W{sMr:H`)Rt'wK7>nijXɻߜC "R UYjWZMtVZgb`AY ɑ@1vD>2CMRVu\-rXlϧEݿ'Q@Rp cc@* +D']\s ΄Yź)CvҰ2޽ޝOPsR!Tk!y_4 !Tvˍ 5g L8Z&ȇ&,HZ[2e ARl׵MYn9"־8/ڜebdh^ܷ>/[DQA 2u^0#Y3^kFN5mr/Pun,'3@NeIi ;Sߎxg.[I; 5MZZH8^;nÖMcX ׻c[(2Z/UeI֟:0W4Ei^^^>|ryЋI7G 1 dϝf p˧dlnl&8y.E/?l3[/5 0kd5F] )EqÞ,RZz]D>U'ꑜdo!9r|ށg<u2b%W>Tx|x zgKRYʪ"N)Yu+A4˻;fdR \{OX/ 0 @>SӚ- 6OߟS՜\c _mi,+K'[WŮܞ-["jc3rb|2fI0 R׊rdbe+X답wΗFi&H(7AO~Okc4ΙjUދym>RG3t")7A 6G$t#YkeGUx<' [K Iwİ2Tcuۘ Gbxf0hQggR&hʬjLje)'.I*M>Yp#z* t>ʰ^a]@EaDeVD#BG>%ed'Զ59s]an?g|89YVrYX5Q<(ow~%= MZ!jdž!`6t5FS+>,_˟ߒ#0T*qɶ^[#LZe Gjz$iTp*K(AI)EAOGBMg,H8 ?5QYDn4c<'U*Z!blRB 5ԷaR%RES`|.C"'1sўRHR>MY6k0>ЄUP* Wsx1m$f;*iPl^?hN' W,\0gMG֎Y `I@konh2/Ϗ/WE (Fma *> 7eo9RYs}Y_6(OGMjjhTkݕlM5&WW*N3HqM>_h&K6&TK"ì͹uRU> n>7_MRkhUkkKP|lZyVhhqo|,f3ɷ=+t߫g,JbB)̳Bg@) x:3`/B!PlLDa/ڙLM$7i1 fm qUYgǯ +HY|m٣wYzTz|~y QM2uV!c66Ua`?5@\=[Ʉ*  km{гpM68.@l#Ud#eX|l(5J `Lぐ2 Fe:A30OAC!ږV=쨒SO][q6Z򮦪tc_ 筂LTvu.lfDDNQ{!>N 5y\o^__󗋅/Jyss[ըe. T1k=⫩܋A۪05f8y8 j]ex#g@!5ѵv:u:O:䚕6m~%Q|tǤm kX:1 cW< e(]]-y&oi`Py3j))*2OQu0NlMxL:m>wp<")r~ơ P]ûzwr+MO'җ^Iۏ۸/ӧ NEti$ $p=Su,͙3 !7HXqk\80 ӿ?sɸr4U} '*zjw'~۶c}ڞ79P\3c>vV=I*H'c>eȸb_H AeA>Dpy8eEOFQW1 䈫j23a4s'ղ{4.VYLAsm 5sK V'V W/z5$}|y/~ tnE3[MA }G}v6jS'YOzϊQQ4 0#L}:դūJ8x5&ĴM||޽0MJYgM*M~NlM¸/@(AG "2BRi0QH` TN0v}\6;i<ک4M7f4h#:Eq#)XtmR7 ]gE?l()r`L*l.^l$dStFWW, U]Гzd;WTy6hp BӀ&A(y_(8(ϲe8+7_MX,FCMOȀZH9(+TzQ!( e8ős獎mwNnhXe(oB^֊:OWx:NDJݶ̮k9p}[Oۭ<+d`S/R\W+gWֳ{mKW˥ 06.Zy zT!6>[ OBsgz>m|3sME*̞^֤I#FVUT]sjp 2;V)6 Œ2a*3藼VγE6<'kڟ"i>g-r4xi&E||}wdښNa^&|LfY3u`g: V~KYsXRŽulevVرlXE,8v䟤~5:,˲ؒ,b &7&Kv;mz A. F>>; IDATQC"Һ!V֙:;fӱlץVw`p.:X2c|bؓ#MX"S~}1<:X̽nz$O_ E_דs.!cwg3Oet'!ńFaACJ7GW>>tr[,i]#n^=>Y?^VZ^h=“(=*P9pz3=v7힖j~a;n)?_U=t6ުo;~9N~iM+-:SM V86 ,1?,JR=ʜ)2/L椸ee\⊤& U?حͷ_MeB.s V&N 򳢨}g~GAlv9&tקMB.LEŊldME|a? ~? H ]r%Yrُ¸EQO|d˲,㎾*!i2GhCC 2w]+ 켼 *P yC{Uj.~7ooF]1 b~xz ~xXnzsJ] 9!ҀɃN \ǰ0f7IFO ZEEv \ՔEYf0[ i{-Uٕ)mQiDm ]IE1ofU{saBU:V0ٵ_59-\jc!m f M{aWV,TeQഐvkýñ%@>;@yc{ؐJ=RY Qѱ>^SK }zItv[o ϻa;6z΢p2ä?)VڝHl|rk\|E!NœxвWuY0nW3Ber1aLr #v;ZJkK Cq4O1 +l΁F;@uƜ Hy^ߍnC *PR6JG4v6"J.%Xez/iı2 ؖі&α4x㋁|s3{H#Uxp>Oҏfl14% X6zsOpR=Sґ\h =vTEbP< 6%t0sI(NEǓ{ .&ƀ,6%&NuUzf5ydђ2 #PGa0 &|)7HBVT 5_CsG7mCšs]9^;т@0Ql$6 ET's<a K n(6kC|kL *U\\\@e ~$zAM7pNVgDlݮ[\e5 \2_io4 z4 .tݭAVvOz8g"␔ \M6빏 qxC =1Hs(c8|2O&7z4TҖKjV&-$Wa$~i0yL(xJW\ΘKp pĮ9$'~6tIR]Nҩ?Ql#>K"ɺ1LjKn˿Qu}AqkDJIX6"c?:P,۠#m/V]*FҔ$2/ JDQK*_ \Sd[S qٸ j=O*1^㿯$c0dKmTC 4q }#Z5Ւ4Af!CZةrIjTP ZK_Y!nWc?b%=;a~50푓O^$9& Y}ʼn׍ctH,"T1m7W`0Tw@cMaK}E'c]z0F~?ʪx]{.A>)aDcg"\fiw~~uwآJcv^[>H-tG9g_]+%b%{".c^H8.5& >*xBډTz"Nǚg0[%Q$oٰ3w*r{#>M?3NLnTn]?vxԿ"^Qָa<(gH W#Mf]š6 sbrֳ8dyu TJXUE]J)I.GCy$F$@p֔h̨BdQ~WJ뮋th!"Ɯ5 ƴHKVDC)'9I DzbjB&0~WM"S;Yz"i*ˁ{U =T6.h5 UۍZ:M=w@Hϴcc]8qU'q{$ حW>;AXQW ]A+=kF Cו F ӊ!4f}:lduRb-^ vY>_("B tkS\ERDft eV~"- U-: i" bˮUo>MoZl9Tg>(CCs/ YM4y東4F=Rc:\Jz:~ubar@L}9aR8/զ>L1=7 ZHp(hv3j: ![ b٬0,s8,x<ze;Ru:@T| ωb ګ9NvSuu=7s2ƀص ȘZq2ѷUEơYX>g箥zG¯ݦ eYyfniTr@?-O&ELVr˲Id^X[3 #A8{x8 y _XGC(T6Ԃ?"16vmr]5^'bo@ӌnzAAԏ)=eY3JetɌ['eAYN+UAՖZ?q]fC=29\e)̲,kY sY,kY,a1,f1=X֟{ysl[F#i4Ҍ(wHO\d6ճv*[kgle-a23B#0:,C}&҈EQ(E4iiVU+RVeU钩WgÀ1#4ϯjPe;7I›e%5IkRzpF\uz*bq]l:1B8"$ n=7E|ZzA[)b1h:J)ɘ0KIKV:/9Al:+=qqMs .vo{:pO O- )*iLҧ!v$MF$?U%}Y[HP?yzts)H_;*MϓJRD3 \ͨ1ٻ^T۾uyd<Y1 dz[rvb$$1=] C=*Dj%WQLDGmoI,n@c''QEQL˅n0f#)Q_asin4!|6JTߋTC_˄rF:!FlvW/]uN9 $g${}Jy')#chB(ȏIJA.ʫR@8(8n{1!~Ll);nN|rȲ(No4(4p7r.5Q|(81MFpͫ-盾[['lu$> HI_/gk+@OO+ʈNwD&Amciy:yN}9ZwYT|jH5esաԁzRӗמ񮺻)Rpk]rkx+Du˰B|&Eq9KW٥~3?dvGރ)y Ԝ z{6:բoOfҴXGе˶R|z2T1eEvGD/((J%x t{+= KeRe~/. wX;Ӎ;Sj]}((3ˈ0?dR>i%q&qLq:l\^p-b$|.ؕ ]yuO.J.bj~黇™4zJk SNV5J dvʲjPU@92`0Ip0[PA\ĥRW=zi[UD~!:=`S"kᑚh(,6Vdm?iOa'7)i2E#L" `Hs̸UjUFNzc҃heqW70`4&(n%\ \Px,:IҜc1N\ ѷ*Z愀F}󭭌Q m0GʦLz\I)erN1**ҕh.w0(h=/ *릡 j2f!nw窫hr؃Ao| IDATn=:A$i5͡ :7RR^=%QJ+wy/݃JJ)e &s諟9p ) EW7)gt=OnۿV嗸})G'A]=<&n>_~Z9y@ѰYH*nYtX [p>- 2/EQ8y̸nPPLl TC&@ @Z0BZ3aи+WnAN8%~e EjݻBJQm[.UL18U;!t"EVUD(>,W-@e0G)xP5}՛f>C~֋VG|\_vZ^aִ~id9_֟&ٟ"ȈeOqz \H^׎V+POS1@Ȯr>~Q^~? )PgGFumU/YG HHur%zM#,sǼj>K\^V$85+ԓQ,]`El<Эڌa%Γ^ꏛL u (m_Bݩo 5[5uG1b(^:Ey($֭ biU|#+#׆2K&yyJ 뵋&pV눱<8G? GAU>}yQ%lX [Ey<4x" $0\]U<;E,ݎo&/Y8!aQ^>h8sLi,/y0,/}EBR! (#H>_}]ŮwuG"JjEr"Z_Y{necbm҅& 2aGY DS(U,xܮ_@y0?l/fwz'D۳ \)4NM:*"Gv,?"Z>cQU= FnR]dgf׈6 {vEkz8C0Cowm=5z 4*x]]훁N>njc77b+ϋA * W-vy_;ߛnVǒISG'>tt$ּ5[=8&!)<*bEmoz݄dC @˙N-tc)E a( y BeY=:/AQqKGe8DaEvhf]^>w9l6OeGB\!LP3\@<W0@aD;" ^.%Q=#tmylH9.Ϯ8E¢0H8g! K#=JIA*zLޟ̮}2kh$˲(?X(].n&wɲT1aiTWeBZuE?ޜAJ=\N"fie?Сn6 yv&ű#(Nl(B(!dێfOyd͞( 1A(" 1L麟&aC0Ώqw(1!<8(BBQ DQǯCJ> _BG>Z=ꀩ R6Ow"Bl:}gt`^H˛@mfބgyˌs0  XL '%3>} B!eb ߧ0N] |lq?}&t&)X<}RC… J2S8G-s]lFőWH+_]!(E_9f(񛏊V{57vW{~4g2@(fgжgao5@٬q/ng⪗a- BM,R]tXb @d\2$;ZAEa!RPkVT yR9$HQ:C3QU} k)UZ.ju y@cd Q&ȐLD;\IdÃdȔU\Qs& eBXvuY$ǜ-X@ֹP]WW7n궮,YRbߟt},s.F1v (9#=3{WJ91w'|~_^!/M]_wזշ# |6뚲P;bʟSÌq6kċ'?(]p$ 卢8w-iq-_Ͻs[r~}˵j6&xo-6:zkPTN;zcFJ|'ߥq\hEU?l9 Q;/;*5{eޛxU"zb8ŢWZʅnq?yS*mQ><}vV}g4v)F[C8GaC P WW릙qX:Dh&%NB:^!ڴ87`$2N`9΢LiHzg@pN%A3ΖU(Ae,&IiftXB>`%حw_.A_ Ij5((@ԕ$JMU *CupybwWZU$UNƒSuMQ:a8?UlɗӶ* $.#slHV%YW9˺a,ш M=NYĪ:*FKVLD;M$ue DМ{4iod(Z qB>xlQ\a&_2lA4~$zmUQ*|)x=K絛/.ץAEuմbP -a OM\{ouTJȐ=16 "s&Szbn I {65at ľƩƔMY"g)냽=L8*̺묵<1g (WqqTF:d"cäbή1{RyPa r'W:I:8qdNj-:;K LPOFNN'`qBvpH__oƶ@~ m ̼"P#Y_<ۑ +v%ӓs@jBT&mξ},wJDq>I;iRwx?)"r>mCdt ed2$)+T5L1gT}YMI΂0FW5ćq`Mٖ^ۨ".ãd:U9Ïܴ];ABUԃCs$7P:;=xv}dmOUC p%6=g@e IIdrnQX!PAB.)C\aS7:D(RM^#+:zD#Q&G:9zYOBYx>6#m< 1j2mm~~P}eowX֪Bb~f KV ŃvPމyPI&8( `aI9à)j&uvӯg}l?[~\%I@(HKAb$oa(}   Hg'QHdK*:6s@Nd, ?>8oƦ@`[)C}wR»Ի?9889<>:+~2q32?ܺ~'<|U}-gSPMoo^xY/V1^^`>8N[AIc5e#()Z*>oְC" h¡ M(vO2<=MXޟ ӫ{mRʇ6G.tBE5[z"Q7w o~;˖)uX6䆣/6]pb<>Wk ??y8d >Ͻ`oޢos_>/.S<l{b_̓C]Meók< Q/ZYIAJPhA(usR\䠐=2Rrr98't;)h4"XcD6IU56m}%d @"PjU&'=XJ^Z-ߣJ ]jdb5m2r,%kޭV۶>}iHTٱ+`UQBn2PZ{/R9[c\H)eD 3k%ʘBzU=[tqu} V[cV#|#'OE˦ 9N'ϦPn9rȀ,|8z V@CI%Lܡ He$)dIq~T 2J{".2هTѥ(3+)eyQڤ]}9x+s<>RU}xϿ~^ρO>}إ8xB::xS xF x6h HAV/x7VueyXo/,ӉoUUjpsu?[;qׯ_>ETlґGĮ]D?]}6lXc2nn& }5guB')'2TV܃DBU%4(eKLb$RH݁F?㪧wpVav_U'ou)ߺzi |Rݬ ;LrvL'B@wg| 1cޒCm!KTb5s`0 98:B $}H8ywΜ*K ![q|J"$Cz:3_eR Qu"M0VHq-]Zm9Lg ̀%=m.Wb mk̚9%ANaf!x畦"ZC@lN}nj&|cVe)9fRjqk߯w?fuW`[p9O0!x+l r8o DfSn~Ϙ٢AFr7ӰZfc]x tiU/Κ(<` Y4ܺLk7WD9gC F$dH'Q'({J&M¬N߽SKqt:`}vXCfN Tǂr$"Iґdm̚98o0V\;׳lʖZ{|b 6%{F2]>dTtm$@2.5i2&ԯb. ,D 4>; )1,oⴥ{we2ܱ1y=RH(HA$afIV\~F#?o)>^Mߣ% . OONkZ/y/_L?u´W;2@y%h&=CUR̎gqki=xٴ $߽CJY)r"S6f0N>_N>\]l=KNkDćhCDB!Eew h9t(]M!P:dxElf].SbdxBtʾQdAڅ'I)Zcl ~0Ԯ.]i b#8Ew-&./óób?dR_]]X%|b|gU_ŋ#/B쒳Wmjžb,mJ H>(:B8N!f!ʊ>D{#;4|7|#yAXFMb=kM/]c$Qko >]1NI1 ъR)&d!F]4Q )\i"%b:fU#Fch\O}p~?HsJ>樠 Ni6]H"2ac姫= 9p1K]OJl# I$ײ9g xHoS/oH}Ϙ(H)5 @DՄtI@ A5-ro:_nlۛBHW?h% ? ecrWy= 6BaSs/ N)UlAETT*'cy{gjS˸&R]~lbyc "хP@%tleHʐ^J†ޏg^{O]^R6396fbCCl ,۲+c]veزmbAAI8KPbX7p z7{ uWB`" dQxDh gpd -!w6JG1j ת0VK ;oܗv@,/=, ƌs@@e =KQ0!GWIi$2AdYNNr3Ȩ|HPZs,(,]#"rs$"P`P;e3J+ %Ybܗ # _\ i+PYB @(ʋ /VVnV{ Zwei-cOa˭E7kdغh]fE<`˴~J"\k]-t3fX@19</#MςO{jHSWSh1‹o'JzgEcUb:}SmoOscgR`6W~6{b84Q͟o&xҧ4OT@: =PA5/Ӆ *2YDz3BrJo%(CD3<c,@FZ+) dhVq%\t$(<.!:m, *2B$"XZy~5IڲS&Zǃ(Ƙ|6Cdqf^ӟ1@q^cCw i5INu۾Y[U 9Ļ^ƅU𶽵V#g,D"k7 SY+@+cF7bT$529% i&5Aw͕ {نGh)?W_WI$iぜLgRp0~8mvh'u8)#,")kJfj‡*g=דhxYmmy#֩SVb`}_vNWu 93q ;߭G.~ǜ{)ۖVRx7 Ζ߶?SԼ$[<J!A$B < ]q$ o:ӓt"YrB$|oN8V#(PvUtqφ-=ڭz=,ҧ/cǴWfق@wP.ឹP׉P̨Zx l|t=ed _%ϻ&ڷ(M=\*JYw4 W#Ki%*{D@@$!ϹF_[Q,'c'.0AėPd'pxa_ա ͛aאPGyx͔--ȲǝTXm +ZڶQcM߂<2F%'.EXQ;~a+6 *uJGhӭ6f;v"׋:^foLi.w["rwTzlmgulj^Vk=@EXJ?S {scYRed\!xȘaRh`ovnN8d0^_0oOC{wгZR#_{{Z! (϶:&i,߫:6%#OZk z+Wǃ#4_ ㋶h&\hk(RR@kU:d(9Nxӻcтv,rQ{x [5jݍmMۊBqeom+z_(GW[=Cpjx jo9 -EQMsy+؟Hy<\_Q1^_舩.BeI@eY  ,  yʟ&w茳N})9xՕ&5vaz/aBC+|:Ske)7&4k#McvQslk~Cp`0<vǶ6joێ *LIgi3sO О@BpDC0rEzADgYiA$Ldm=Qw{qҿIݎmķXZ1: RE+[Sqף-EvϴzB50v ֟W=rsuw"!ZJ?F ]ziqA1H8vs=}{*裓ms<_.ʠ/y\(Q v;snG o/ֿq맨@-^Fչ~}/8w=\:uƺs#| 43@tƀ䈘I80 @|zn~>#!Y* `qKS?~S6yKT uHJuS(Qi7 |cy]u]A~xqַ K8}xBUrp}" at$"=Nv}5K3@NB"X& Y#/:f z.PSݖlCv/lg6[&sXց+"jξcamy}kPKGkҀק^ӰCMOz)waϥL~Y[9CqY@@J(,9bȜ5x<E`U5er5ǞsرR-\hv-%͍IbUv]/=P9S{^[:Kq66pOεʕR,5zĭDn J+sfyf gNLp FK <3==UmM[g[?o O[*\mҒ묗Ո1o/F^,8ۗtxukZat`p\$UErR%UDd>}qʦxe qάݝ– 8 B*7j,<{e*Vz;vҿǟOtH_죬U]aH|MNSQ_@ fHtA|Qdz=L~,JiC3I|Nzxѱ|~I+Z6dQBqgǃz(˧ugGF:y% BJ!/(mIQπI`:",8/&p,cY_!LcP95pԝZ8o2)}5q"qTa<Kj ʭeyg)),c=IF߾GHeki X'$Z 'Aa<¸~ua3.C'&;?bHΖډFNjQ{^bn~;_WN&mߗ: 'IFa*|4jUMNάqDFe%∆HKr<w-%Qb%28#)U#_|vrxW{n<Pͫ mU(K,jVĶK.1|#vMgG+v:j?{W 8Pf 4˱YslͰ ̲ ۰ LX"Pbjb-,'ٽ-ǑޮY CUsb@*<;i:-6aя\x׉ GZ^aP N4J&kPytIb $u^4|ghL^!4{`^rH5>6Ͽ2#zJI&e&t~HDL0|8Y.,~),˪غi&Iβj:{סa=pz4qͻ{\PM5z] di#n+<X__xVq^ |/\xlzx-} g|g)Ȣ(̔駳$M-+<ݩO򗓙Ĥ|~I"2dyz4i>c7Upykl-LoO'P0cGM7͋<< u7а( ? EDg1J0Z|)c=a<>x EX s{IQ51+f"bffHrI~ysJ)ēdՄRTtβˋq<ч F5Ln ޔ4" X +~D<5eʏ=v}Zcf2toh=nu5>g"^Fv5~<=ݫu[lh!I|Z-'Dkk`SULE/N|P\br~~qZ!{k꿩!KTuD`@E[2A'4uU24i ՑZ+ׯ=-ScQ9QvMl%r?5b$4vj#ugcc9Xr;b{et^~}m&\o2,sMA|~~KY&$B&,+6,eB$jz,ч ^1v@f}FVCղﮧ٦]'MX^x&% $u$/ړr)C:j , uI9zxU9{T#~, nTvS:xCÇIY;$8W;k/4JVcXmid:ƈ6S;[aRr->^_3W6$lu<_.oy^|2TJ 1M%!Alyv2Ϧ#p`Rx/0wL#vyǠf9B>Ɋ\dX>᭾vO[P+9jFbDFbo20![;"f1pM;d8zg(40. YB1|qN`Py~}s]sfmT؞{I :٫z\?o~EJͦIUT TR8].Vvp}ɣ^վr^QA#)\z m .˲Tө0o~dD^`m}"{h?A=SaubLltj êJ}ǎ WҠ,+ w׉8?}G+u/cxP`BUm&$.VKK/'o߾?>>R%CL\ʪ,&OX᏷]/p&?!vq82zfv%Q?cRԒ kA([vv1HXa^M?ʵ~ Fa~U;CBS:Wc 3HLGq6x=>pCdl})uss#<_?IYbS,SN?IW̏͏oe\&jj"IfYVxS|B1p7Tx ]S[Fj츉:#kl2aݬj^uB4n7xc?vp@/ Y0_Y=W~,Jw,V7p z)k[#{>sʋ8e ._MwX\XVL!޼.1i3-ߕ\rBTΦb$ei~Y\B6ƸZLReYŏo UB&ɔ6<;A$D6$lyDq IDAT%[ϬEK9OתR Bu1Lm @}]`nv'n~sBFuR %lk.Dۺ<5Wv7YPpj$C.9Te,(?wPf~ =s5^'oHǚ&J/V4Yτ9\GmxHcAxé4vdа% i f P'U3QxxZ߫J 1(lI.rW߾wLs%,YUXRn4MYFӳ]D9K.݂6R~\~\2=`GT#uj$}FEm4WEIц78@/6GұպPߢeB;כ,-˫/GĀVbcؙu{3lor:X?`/A|/o}^(3o]A}Lתy2YGi笍ECzdptzHYWʯd(h-@]+F8>#|.{{X["WYHL)PU \( ɗ2foݷͥT׷7\&<|R Tb ݏ}Jid)=edkי"iB{#gSwԎDY-Khk2jǿ,#5y,ideQ^,˼ujْ>1hIO\ ۅte\-' G;;1C)&K迯$ޙ<ѿآi_S8.l3vfmL{kBoެTVً߿vƈo\ŵ\:vܹʍݷSGm:g.E6jF1X>~+gDDXV(xɒ^^RL$?sQ(Ȳ & J4K ܓ:Ye.~$ȥAU19I6y !ֲ $z47 aPƟYZ qOuF3o 69 <릶;wmXǔ˦6ӹ)SԎpisQps s]–37đ#o`P hK؛ߘX{];; ]wU(TBCmxZYu͐G?/#>きдjӭ1ƾ 9 .AA)%.4UPIxI<"M!)PM6XҔNO2ΖY6Ot.bse+Q*S39brYhm3FⒶ#UO=t `O~bCۙK'@Uo 9`GWE&Pn^óΕk?B+~,2vEE\;[+3Fsib`P<ScX<11́6n1L bX518y&x!ÊjOc"adf4j{{Q^BU~xWEΕ0AJP +{CL,ft1%sqc! I2$䓬lq?V#d塱2 ga ѧg-z>f]1Nο B;s38y OcƑb~{7nq; bA00u̠oзVusoy`M [6dk8dw\~nMg<(Hþl ͇`o碐i/7WW1#+w[{獩Pj^ RyXkOhb@R$m"\?0]rdyMEmkV A'kA)F0n_QDu/(-) e[F"6`赣Z=wV #{C(^o'^rh34iMAہaԮ^R75܌>қjf*d⬬)`2U$ԮG[в7Mw֓l!m5+}--ns\]v{aXV?!0apûvv=x$k>1{3,,{ ,z9y ˂T/j8ι S4V#!(-_?q-c~BEB~jAw'bc@;IVAӁvp\/a1_θ?Qru eo?5oCQ, l-@9 V'Jb(0=;OSkm/:K#kk-!yL7ȝ@䨃vmucd-+K1? U\S07nT-8]< Ƙ`:z N14՘tl6i((VAry,Rtp{Ζ4~amܕ&s*ȐD2Ms_MXY_fRq6NIyDOO.ՋީeIVwj:|bռCp P׿?ӗEHC9li̕*o;|U8GuY{6tڷ{5'yE_6DŸ-+8Fu޾ Si+4%zAM?r6WL] QhĞ H_[?,FT<ߚG)t{;dAWߵ;-PUyl78.u~ND"קycӣƄMPG9`G TϿ*vj6GiOuZ 瓾T.ݟ3̲,=M29flD8H}t,W* $_KS'!NR.K fBF{?:jʍTf-Pγv6[5<!)DlV38b/ 5523LYjƜ8j錒]"c8AC^c}a%̣a:!TRۏ>_@iLKqFZ0]n6* 6Orn,x6: Zs{Anz;&9$t)"Œ`UϗWNk:8e|d T=M/Zb8G?bc4eTi:^ JLAQtTd\6m+JK?Q  :JthtQ._fkVԴhռX#|t4vS#@oFsOnoTG*n-f 3 4zm.w.\ȤKwr8E#:xN_EI6C˜xf e>jWlјq-Jo|׮!5zˢYMaqmG_j )ӡf <álb5[LĪn)k c#/کcZۖ>eҊPX1Tg^}2}IQB "Ǚ^x QW1=ˬjwtLB|U@uGNGN+^LSMA2Qx!VG:Ӣ&)oQ@&>xaZj|z揚>]LC9w1Bhܟuh\U^D5k˸e *$vN C`W@C wJf.nKιf_Rkw좽 a*J%:C+ u$0o)djB(҆o*v:SdcYm\j< Y+nmU}F@T\|yY^g^|7 b Hj͑Mֻ̿c#-TֶٔLÓّxG-x3iM3a96C N~C M`x1Һds2)~HH~a[-*k:dN&lʈSf%d?IO($.metd*VBw i,dY,SAӣ>& ʣWDǮc[>47nhh̃6oT Q, gC{|2"8b\Gi- ,AyWz/ʓu!Z:v2S ت Qi#r.ts}*SQ^=0cQ*(`Bv;ׅaآzWv#\,-p9V¿) ބ0dfѱ(g)\q$?N|d uqOjVG/$x ˨rNdSC͊7][bE_yԂ3J^+ɵ[-Pv8dY=nJS<a̎Gdv'>5VI Բ-5(nݰ}GQn#$tDuEr,,&$ī1tۏ-8۳s*9 ~ *%&_6I󴵳b/Zg8 ` W:s'\FgH*|>ҡcA ܁u4Q2\irSzFP3V_Bvzuy3 ӫ3Faf}g3(zu_cNt^p q>2Q1gԟtʐƟLK(l=#$"m{SNfQkVqe]v?>*Æ㬝>l``8<-V5qL2Cz!ܫl⟑%{c}f sޅuo2S_hše~s6|҇;|71o~"fl4Yr1]e ykE8pE+Htbޏs e\ZtQhRg;|l5"T eoŻB9׮=$-/Cs قx2֐X(<+װ'M3 k@<:Uܾ[:zB:+U1cTԯ깎+>NgyXؐl^gN/(NAG$HjlVXtL4kK-Uj0MF:͎]&r&vj}-Хjp߉)ӷ'9Ŷ񭀳N@w6K2Feo/Jլɲ56cūMFe dhjcQ$BlYf>l lFdXfKcV@o5K^b)IX棾lf?lT?Nn bk?:>wu C@֨RP(~dcq]d'WGl]sjFf!MtbMsZ.I SJ tooKtϷX-6jxyzr۾BҥO7"+ޡp2<3#aZ캛Uh$N;p'w (4jV ).<($ T/!w&K=5/Gac )g nT\!DZow9=8Eﺻ Scn (Q6?BYʣoJGlhmgn?mP#UA{LumKgBgp2R՞}qs0dM_˜W) 6h8ٷ3nI,i`5k`  ]+L5|1FP2P!8 ʣd*oݺRńiƋ{Qj't=Z+2MYa82qQ{0ދۮK kM٪$US8[Pܮbgm4R7[a@ 8뒬.;a>|e"[O >#/$*{e{3ӿPtvzR2qnzSFYOtQjL N,;amOpݚgg':@ջd*,j6hBˀg zy9C#ّAq!O++sywNO¿&E0;xaK.IHXf^t48jW@ltpC٦͓s3EC?=V.P?q>SQu.!n#MBzr;fbd 1?$:|H!Ci϶8pFnw#~5Or&8?*_T Ci3d E9QL.~ Y20 ;ڷ*?Y;rNru9wq_w5hCW0B?lt"Vnǽҟn93cfܒ)ں[cp#XWeR6[7q~ע Dg;iJUoՅ-[ P[P/p@".sT9 d@'V\ %ܹfEP'M, 룪b_ ~Uk:+d dƮwYa#Nد(#{c]= .]B`*U w[t;׋35O(i,3`pf.nQ$R2!x?TǸ4Z1usa?J .#d&_Jbs^o&&[@(84-XT⣃g[!j?%'+l\.F`=l.,$|LbFhF`K]t/NUO4DT23_}$C^Q0!eq͡&*XƏQ|,Ikz4\#u-km{+w,A~$V6([~^SO8Tݧ!8l4nh>[)1‘/ȿ)Co)s$HVF1SGd/s&l#di.W23s |BvOkN&VTR݂|$8X'3l7?|Eq5B*/E -2}{ڛc'lˁg;$qH*5\Lx\}'5ELҮ: ǧG ս;C-`\Ϛ!)Mmp q ,ԌVX&L0ɯ ro(.ޫ'L_&9oj{x˂2iC]QB19Kvg\' ҼtV9௺t&0lJ%WǞ;MɷݨǒUi]*-H̻Wer Ps j+em_Ve _mzW{(5&IhC :ImNV^^,}au}A2N./n5Dp+l>yLݦZP8;ԖC̥E1mh!eOsR e~gzeP8a=:t6OFCۆ}ϛMAC7ݟE8s;_hn\|»-DTut,=C.|-xG *N?;f.G6/T 颍"-"檽VA5dՈe^gh˘Xif$K8W7^6{Ih":a/{J_DhYJO+xV<NMW}`\#>ӵaiZIOZ]YC,4_'S-J\P֯BV^G.á xQN`ĊN:mVa..i*JA!U.7?&|J?;5zYޭpmֹB0.5zP]:L.դ nWttVW_|gaSRBߏ$m57`AO·rI?~k6"@=d~붎!bt!avʐ4φцZj*m]8ܩzt֩  #G^pAxOg CXX/ jYR8pCi>%%ؤ:hR)"Od2@C A"APBܕ +~ vG|Ey`RcB`OlD]7@m;jw9r-]g!43k~-[$ &/ 35,uEt#dQE> Urr9rիM֫3g},$0WPMiWCs!7Ď+ 1 Jͽ%e\i J&MX=bd{~\)Mc  ?ԉEU}o4 ÉZzk74#/KLtыo0^q vW4D9F5G"24XMGR2YG~ƙ.GiS7C)3q[Dzh1"j=\pwEaY^ȽHX4xuqzqobn~;4GHvB7 uk5흾;T6y ,@ޕw~0u.P@lBk3Tˏ%8m Ŷ+J%dI'YtDǝly9ڜ@졮UIC?FQ_V {|l'un{WfEbuV{t-8斺N/ ݗshB3HɪvG KV˶-#6945[|" aSGܞaȊ`fmK8>˺ŭx&n :H}g\AҼ:Qa3Ii&&e gcjEҎ1cE0ᶕV0=Y|/F/%054Ŷ1^~1GFn}n ~ 䘗s .;Y+%;&di ]Q>z'~1>E4NNS+$N(^9rK-=_=ħZ@0l2QG,pmNpy]sN/ًNipTڨ%Ô>W'C=,J8ۮ@A6Uϲs XB3Zl'6=W:kN7R3_ b>sZm!qED<ˎI379Ħosz.- ms[N@o)*jq'4qǨ.2_=;D6X+4šMq,: }& P2vPc eꥺW\F ~:q}\q} *jpaWun6?zH|(.Wj%dƒroYu S)nŭء4ts':=D߁Aё}[5YǏBs0̤Sv@ޢ9rLb!-+0AøvNlc\qݤd %W}|䰳Uw+A=:ZQE=ɺd\x>oC7'6BQr[62mҮw;u= &ivu1̌\M Ժ+5KY~Ii$RUȉ,">XмM~xOLxiMȚ[\# $vQ"=8U'k _RaY^L"Ąc;/g\YXF5- ){TnŚD.8/m0<Sx'3H}7?k:'!}n]Z$ͷݓ Cȴ>UX!s]GN@2^eVQ髝>Y28#w~P7zG#$|dUj%?ȁ1x_sLu _:kʱRD_yv iE>%]}F޸/эx.W.6i =bjd;T+%cH}/Y|cqm#s͙,z%)}?/>N-aaX3Z$c&^tL G?)_a+R {25|R P m"ҜIciNekscX1s]p?qa~W;NXA@pVIi/ehtc!^ķp{C5z*s{r],:2.Z,oL-vΟw6{_z7cBvʌH+WnE7Ld*Ðu!zn~eX =jڈm#:"PT؃zgD}Fbir)ne8lf.tp٧8C4 \Xn)t dQb8S$%Z_Jٝ֫nrL^_gLI?~͑6f/x6M,2tegj5|5]|DŽ~ð%`kru[خ f$LR8 jv9[9.[u G>P]>H ][*.mjɀd?L9ӮГ>L+(aq]?7l,q[1RS4S:SCp{ ̨nuQ2ƛ%kDK%)D΍ 5}bx_A>҇$%R=<ҹ}IS2M0S4MV (@=؉AߖVlxlu$siHʒJ=%th4NGX7NTSx^\F%S EHeQ&P$4x۫4+S_A|c׽Yt٬Q Gwv3R}" krߍ1c  R" IDAT! g=p . .$1v$^dYaMoa(Ga e^Ǫg= yWo:m85sar .&WY}a(Wz#-$Za\+?jr#etj%UEƇJ`]̔8%O!C˓%Q*WȆD~)*Htyݤ.ZF ܵ`84Kvkn;ZۻSSXQ(C琩Dp6Wz7([rT6G,͸Uq,u)$H#_Vmk9(C} TQ̑ Ly;\Co5;cHG`&Fa']8g%"]@5rԡcB^gZߥіO8dRCF|ꊟHm+lOG䮱j d(™--)hPo/rEX%q0JlPjjJd 85=շu%S4M} Mgv5 &E˶bcܼ(PG}4E I-3ܠo/+ sl)h7Z[zUhVNRP[n'KY8 pk(J>MsM̚ӓ>e*s9}6>AeWcƦ>.Xf^{EswmєYoLl)޷"bgMw2ޙCrVKJԥʊ:iTC'؍6,L-F8RҜ$(npxSr͞,T$nE!Roi_glda͜)U~֜=*o582V$u~eAaz㏺0 >/$![ʥFJrI_k8|6bc&+hL]*Ƥz`1#s&x+왮jR]x$SG K+V1݄Uypg9ET:MM=wXMJ*+P 5>Y|Nxou\Ao-؋̈&$m*ĐF,*"uV7Qr#t2 9|[ }iV_ګX?(x~?#,0p(;Yxb> *g:Y p.vNOl |{?ǽV0;Nn`8PՊpsMl)ybs2 7ǀPLLHRHKZIјܾ#MXT"@G=%S?X͂& /_},۹p'57vݻ ;rdg܍N#+\YQRhGE$ȷhjObj|DtUOdjO> =3Pre$dha$ CJaJtH PO"P =3Def Para$TdP^Ta$ CJaJtH ^@^ =3 Footnote Text$TdL^T`a$ CJaJtH N&`AN =3Footnote Reference5H*OJQJkHDObD =3H1$$d@a$5CJaJtH DObD =3N1$ & Fda$ CJaJtH ,Oar, =3N2  & FP(Oq( =3N3  & FVOV =3 LQ Def Para$dP^a$ CJaJtH XOX =3LQN3*$ sdP^`sa$ CJaJtH (O( =3N4  & F(O( =3N5  & FHOH =3Part$$ G a$ CJaJtH 4O4 =3PartHeadxCJ"O" =3RefCJTOT =3Schedule $$ G xa$ CJaJtH @O@ =3 ScheduleHead !xdCJ*O!* =3 Sig_titleJO2J =3SigBlock#$ X d CJaJtH DOBD =3T3$$dP^a$ CJaJtH @>@R@ =3Title %$Xa$CJ KHaJtH BbB =3 &dCJOJQJaJmH sH tH LrL=3Header ' !OJQJaJmHnHuPCP =3Body Text Indent(x^CJaJbb =3 Char3 Char Char )dCJOJQJaJmH sH tH HH 1 Balloon Text*CJOJQJ^JaJ2O2 cA Sig_signatoryPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] `{g *Հ {~Հ  )>Qc^ouxLzՈEGJLNQSUWYX".{AJN~]yk]1f3 ^aKrMr@Հ@UnknownDH UserG* Times New Roman5Symbol3. * Arial7.  Verdana5. *aTahoma?= * Courier New;WingdingsA BCambria Math"1h-ڦ-ڦچ?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abdefghijklmnopqrstuvwxyz{|}Root Entry FPkV=YData \ 1TablecL4WordDocument2SummaryInformation(~DocumentSummaryInformation8CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q